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CHAPTER I 
INTRODUCTION TO THE WNT SIGNALING PATHWAY 
Introduction 
The canonical Wnt signaling pathway is an evolutionary conserved pathway 
required for proper development of all metazoans. Wnt signaling plays a fundamental 
role in the determination of cell fate, proliferation, polarity, and cell death during 
embryonic development, as well as in tissue homeostasis in adults. Misregulation of the 
Wnt pathway leads to disease including osteoporosis and multiple types of cancer 
(Saito-Diaz et al. 2012). Understanding the mechanism of Wnt signal transduction is 
critical for developing new therapeutic approaches. In this chapter, I establish the 
background to understand my cell biology and biochemical studies of the Wnt pathway 
as outlined in Chapters II, III and IV. I conclude my work with future directions (Chapter 
V) based on the results presented in Chapters III and IV. 
 
The cell: the basic unit of life 
Signaling transduction is the process in which cells detect changes in their 
environment and orchestrate their intracellular response (Gerhart 1999; Alberts et al. 
2002; Gomperts et al. 2009). Signaling transduction pathways can be characterized as 
a cascade of events triggered by binding of a ligand to a “receptor” (often embedded in 
the plasma membrane). When the appropriate stimulus (e.g. chemically encoded 
information) is detected and binds the receptor, a series of biochemical reactions occur 
that, ultimately, result in a wide range of events that include changes in cell metabolism, 
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cell motility, regulation of gene transcription, or even initiation of cell death (Gomperts et 
al. 2009). Signals sent to and from other cells activate signaling transduction pathways 
which promote cell-cell communication and allow cells to become organized in a more 
complex fashion, giving rise to tissues, organs and, ultimately multicellular organisms 
(Alberts et al. 2002). 
Despite the legion of metazoans and their significant diversity in morphology, 
reproductive strategy, nutrient requirement, and the ecological niche they occupy, there 
are only 18 known signaling pathways in metazoans as distinguished by their 
transduction intermediates. These signaling pathways are required during early 
development, late development, and in differentiated cells in adults (Gerhart 1999; 
Meng et al. 2016). Nearly all of these pathways contribute to human disease when their 
normal functions are disrupted. Because of this, it is necessary to understand how 
signaling pathways work and how they interact with each other (cross-talk) during 
animal developmental in order to develop better treatment in cases where they are 
misregulated in human disease. 
  
History of the Wnt pathway 
The Wnt pathway, named for its ligands, the Wnt family of secreted 
glycoproteins, was discovered more than 30 years ago, and the historical events that 
led to the discovery and naming of Wnt ligands highlight its importance in development 
and in human disease. In 1976, Sharma and Chopra described a Drosophila 
melanogaster mutant that exhibited reduced or absent wings and halteres (Sharma and 
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Chopra 1976). Based on the mutant phenotype, they named this locus wingless (wg) 
and suggested that it played an important role in development. A few years later, Nusse 
and Varmus conducted a forward genetic screen to identify genes in mice that could 
lead to tumorigenesis (Nusse et al. 1984). Using mouse mammary tumor virus (MMTV) 
insertion sites, they identified a locus termed int-1, short for integration 1, which induced 
mouse mammary tumors. Comparative genomic studies revealed that wg and int-1 
were homologs, and the names were merged into the mnemonic Wnt (Nusse et al. 
1991). Overexpression of int-1 in Xenopus embryos induced the formation of an ectopic 
axis, demonstrating that it not only acts as an oncogene but also plays a critical role in 
early axis specification (McMahon and Moon 1989). These studies collectively drew an 
implicit connection between the physiological role for Wnts in development and a 
potential pathophysiological role in carcinogenesis. 
Forward genetic studies in Drosophila have been crucial in identifying Wnt 
pathway components. In 1980, Eric Wieschaus and Christiane Nusslein-Volhard 
identified a series of Drosophila mutants that controlled patterning of the early embryo 
(Nüsslein-Volhard and Wieschaus 1980). This work was a watershed moment in 
developmental biology, for which they were awarded a Nobel Prize in 1995. The 15-
year period after their initial publication produced a number of genetic and molecular 
studies that elucidated the role of these mutants within various signaling pathways and 
resulted in the discovery of key members of the Wnt pathway, including armadillo (the 
vertebrate homolog of β-catenin), disheveled (Dvl/Dsh), shaggy (the vertebrate version 
of glycogen synthase kinase 3 or GSK3), frizzled, and arrow (Riggleman et al. 1989; 
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Riggleman et al. 1990; Siegfried et al. 1992; Klingensmith et al. 1994; Bhanot et al. 
1996; Wehrli et al. 2000).  
The activation of the Wnt signaling pathway on the future dorsal side of the early 
Xenopus embryo is a critical event in the formation of the Spemann organizer, a tissue-
organizing center found in vertebrates (Spemann and Mangold 1938). The role of Wnt 
in organizer formation was uncovered when mRNA of Wnt-1 and Xwnt8 was injected 
into Xenopus blastomeres. Ectopic activation of Wnt signaling on the future ventral side 
of the embryo was shown to induce a second organizer that coordinates the formation 
of a complete secondary body axis (Smith and Harland 1991; Sokol et al. 1991). 
Embryonic axis duplication was also found to be induced by overexpression of positive 
downstream components of the pathway (i.e. Dvl and β-catenin) or by inhibiting 
negative components of the pathway (i.e. inhibiting GSK3 activity or overexpressing 
dominant-negative Axin) (Dominguez et al. 1995; Guger and Gumbiner 1995; Fagotto 
1999). 
Numerous genetic and environmental perturbations of the Wnt pathway can lead 
to a variety of human diseases, ranging from birth defects to cancers (MacDonald et al. 
2009). One well-established connection between the Wnt pathway and human disease 
is a genetic lesion that occurs early in the onset of colon cancer. In 1991, a germline 
mutation in the Wnt pathway component adenomatous polyposis coli (APC) was 
identified in patients with familial adenomatous polyposis (FAP), a form of hereditary 
cancer (Kinzler et al. 1991; Nishisho et al. 1991). FAP patients inherit one defective 
allele of APC, and upon stochastic loss of the second allele develop colon adenomas 
(polyps) at an early age. These benign polyps frequently acquire other mutations and 
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develop into invasive colon carcinomas. Later studies showed that loss of both APC 
alleles occurs in the large majority (>80%) of nonhereditary, sporadic colorectal cancers 
as well (Kinzler and Vogelstein 1996). Following this work, inappropriate activation of 
Wnt signaling was subsequently found in other cancers, including liver cancer, skin 
cancer, lung cancer, Wilms’ tumor, prostate cancer, and breast cancer. A variety of 
developmental genetic defects were also shown to occur as a result of Wnt pathway 
misregulation, including defects in limb formation (tetra-amelia), bone ossification, eye 
vascularization, and tooth development (Gong et al. 2001; Boyden et al. 2002; Niemann 
et al. 2004; Xu et al. 2004). Understanding the basis of the numerous human diseases 
resulting from misregulation of Wnt signaling and designing therapies for their treatment 
obviously require a detailed understanding of the molecular mechanism of the Wnt 
pathway. 
 
The current model of the Wnt pathway 
Wnt signals can direct a wide variety of cellular responses in development, 
physiology, and disease. Originally, it was thought that a variety of cellular responses to 
Wnt signaling were mediated by the different transcriptional targets modulated in 
different cellular contexts. This original model, in which Wnt signaling alters 
transcription, is referred to as “canonical” Wnt signaling. It is now widely accepted that 
Wnt signaling can also activate distinct pathways that do not involve the nucleus or 
transcription, but rather signals cytoplasmic changes involving the actin cytoskeleton 
and intracellular calcium stores. These non-transcriptional Wnt pathways are loosely 
known as “noncanonical” Wnt signaling. My work focuses exclusively on the “canonical” 
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Wnt signaling, so I will only discuss this pathway. For clarity, I will use the term Wnt/β-
catenin signaling to identify what has been commonly referred to as “canonical” 
signaling. This nomenclature specifies the ligand (Wnt) and the essential downstream 
transcriptional effector (β-catenin). 
Wnt/β-catenin signal transduction, at its simplest, is a pathway that results in the 
cytoplasmic protein β-catenin entering the nucleus to modulate transcription. When the 
pathway is not activated, β-catenin is subject to a “futile cycle” of continual synthesis 
and destruction by the β-catenin destruction complex, comprised of the scaffold proteins 
Axin and APC and the kinases GSK3 and casein kinase 1 (CK1) (Figure 1.1). Wnt 
signaling removes APC from the complex and relocalizes the other components to the 
plasma membrane via the adaptor Dvl, thus stabilizing β-catenin which enters the 
nucleus to mediate transcription (Figure 1.1). Thus, Wnt/β-catenin signaling can be 
divided into three general molecular events: (1) surface receptor activation, (2) inhibition 
of the β-catenin destruction complex, and (3) activation of a Wnt-specific nuclear 
transcriptional complex. The next sections of this chapter consider each of these steps 
more closely. 
 
Surface receptor activation 
Wnt ligands 
Wnt proteins are cysteine-rich morphogens of ~350–400 amino acids that can act 
in short- and long-range signaling. There are 19 vertebrate Wnts, and all appear to be 
able to activate the pathway. The crystal structure of Xenopus Wnt8 (XWnt8) bound to 
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the cysteine-rich domain (CRD) of the mouse Frizzled (Fz) 8 receptor has been solved 
to 3.25 Å. The Wnt8 structure is bilobular with an N-terminal helical domain and a C-
terminal extended β-hairpin stabilized by extensive disulfide bonds. Interactions 
between XWnt8 and Fz8 occur via extensions from each lobe (“thumb” and “finger”) to 
grasp the CRD of Fz8 on two distinct sites (Janda et al. 2012). All Wnts contain an N-
terminal signal peptide for secretion and are N-linked glycosylated (Smolich et al. 1993; 
Willert et al. 2003; Takada et al. 2006). N-glycosylation of Wg (Drosophila Wnt 
homolog) has been shown to be stimulated by lipid modifications (Tanaka et al. 2002). 
Although an early study suggests that glycosylation is dispensable for Wnt secretion 
and activity (Mason et al. 1992), more recent studies demonstrate that mutating the 
glycosylation sites on Wnts blocks their secretion (Komekado et al. 2007; Kurayoshi et 
al. 2007).  
Wnts contain several polar amino acids and undergo a series of lipid 
modifications that affect their activity and secretion (Bradley and Brown 1990). Wnts 
have been shown to undergo acylation at Cys77 and Ser209 with palmitate and 
palmitoleate, respectively (Willert et al. 2003; Takada et al. 2006). Interestingly, the co-
crystal structure of XWnt8–Fz8 CRD indicates that Cys77 is engaged in disulfide 
bonding, whereas Ser209 is acylated (likely palmitoleic acid). The palmitoleic acid lipid 
group was shown to dock within a hydrophobic groove on the CRD of Fz8 and, thus, 
plays a direct role in Wnt–Fz interaction (Janda et al. 2012). 
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Figure 1.1. Schematic of the canonical Wnt signaling pathway 
Left panel: In the absence of a Wnt ligand, -catenin associates with the -catenin 
destruction complex composed by APC, Axin, GSK3, and CK1. Within this complex, -
catenin is sequentially phosphorylated by CK1 and GSK3. Phosphorylated -catenin is 
recognized by the E3 ligase -TRCP and targeted for proteasome-mediated 
degradation. 
Right panel: Binding of a Wnt ligand to the co-receptors Fz and LRP6, promotes LRP6 
phosphorylation by GSK3. Axin is recruited to the plasma membrane by Dvl and binds 
phospho-LRP6 which results in the disassembly of the -catenin destruction complex. In 
consequence, -catenin accumulates in the cytoplasm and translocates to the nucleus 
where it binds to TCF to activate the transcription of Wnt target genes. 
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The endoplasmic reticulum (ER)-embedded, multi-pass transmembrane O-
acetyltransferase protein Porcupine (PORCN) is the enzyme that mediates lipid 
modifications of Wnt (Port and Basler 2010). PORCN was initially identified in 
Drosophila as a segment polarity gene and was the first gene shown to be required in 
Wnt-secreting cells (van den Heuvel et al. 1993). Loss of PORCN function causes Wnts 
to accumulate in the ER (van den Heuvel et al. 1993; Kadowaki et al. 1996), whereas 
PORCN over-expression results in a larger fraction of Wnts that are modified by lipids 
(Galli et al. 2007). PORCN is directly responsible for Ser209 palmitoylation of Wnts, 
however, it is not known whether other acetyltransferases are involved (Gao and 
Hannoush 2014). Modified Wnts are translocated from the ER to the Golgi apparatus in 
a process mediated by the p24 protein family (Buechling et al. 2011; Port et al. 2011). 
Once in the trans-Golgi network, the seven-pass transmembrane protein Wntless (Wls) 
is thought to provide further transport of Wnts to the plasma membrane for release 
outside the cell (Port and Basler 2010) . Consistent with the necessary role of Wls in 
Wnt signaling, loss of Wls resembles a Wnt loss-of-function phenotype (Bänziger et al. 
2006). Wls has been shown to bind Wnts at the conserved palmitoylated Ser209, 
explaining the accumulation of Wnts in the ER of PORCN mutants (Herr and Basler 
2012). Wls is recycled from the plasma membrane via a multiprotein complex called the 
retromer. The retromer is responsible for routing Wls into a retrograde pathway that 
transports transmembrane proteins from endosomes back to the trans-Golgi network 
(Coudreuse et al. 2006; Port and Basler 2010). In the absence of the retromer complex, 
Wls is trapped in endosomes and subsequently degraded (Yang et al. 2008). This 
requirement of the retromer for Wnt signaling can be bypassed by providing additional 
10 
 
Wls (Franch-Marro et al. 2008; Port et al. 2008), further confirming the role of the 
retromer in Wnt secretion via its regulation of Wls (Figure 1.2). 
 
Wnt extracellular transport 
Several mechanisms have been proposed for how Wnt ligands traverse the 
extracellular space to bind their target cells. It is possible that these mechanisms are 
tissue specific and influenced by the extracellular environment in which the cell resides 
(Port and Basler 2010). The mechanisms underlying the graded distribution of 
extracellular Wnt/Wg ligands have been best delineated in Drosophila wing discs, where 
a gradient of Wg protein patterns the boundary between the developing dorsal and 
ventral wing surfaces. These studies suggest a restricted diffusion model. In this model, 
Wg diffuses across cells extracellularly while interacting with receptors and cell-surface 
heparan sulfate proteoglycans (HSPGs), which act generally as positive regulators of 
Wg signaling (Strigini and Cohen 2000; Baeg et al. 2004; Han et al. 2005; Yan and Lin 
2009). HSPGs are comprised of a protein core decorated with long glycosaminoglycan 
(GAG) chains (Häcker et al. 2005). The importance of GAG chains of HSPGs has been 
demonstrated by studies showing that when enzymes involved in heparan sulfate 
synthesis are mutated, extracellular Wg does not accumulate and Wg signaling is 
reduced (Binari et al. 1997; Häcker et al. 1997; Haerry et al. 1997; Lin and Perrimon 
1999; Lin 2004). The HSPGs most studied as modulators of morphogen activity are 
glypicans, which are anchored to the cell surface by a glycosylphosphatidylinositol (GPI) 
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Figure 1.2. Synthesis and export of Wnt ligand.  
Wnt ligand undergoes multiple posttranslational modifications in the ER. Glycosylation 
and palmitoylation of Wnt ligand (the latter mediated by the transmembrane protein 
Porcupine) are required for its translocation to the Golgi apparatus. Palmitoylation of 
Wnt allows it to bind Wls, which provides a mechanism for transportation to the plasma 
membrane. The retromer complex recycles Wls from the plasma membrane back to the 
Golgi. 
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anchor. There are two glypicans in Drosophila, known as division abnormally delayed 
(Dally) and Dally-like protein (Dlp), and both bind Wg in cell culture (Franch-Marro et al. 
2005). Dlp overexpression in wing discs leads to extracellular Wg accumulation, 
whereas Dally has little effect (Franch-Marro et al. 2005; Han et al. 2005), suggesting 
that Dlp binds Wg with higher affinity than Dally. Genetic studies suggest that Dally 
mainly functions as a co-receptor to present Wg to the Fz2 receptor (Lin and Perrimon 
1999). 
In contrast to Dally, Dlp has a more complex influence on Wg signaling. Dlp 
inhibits Wg signaling close to the Wg source (short-range Wg signaling) but promotes 
the range of Wg signaling distant from the source (long-range Wg signaling) (Kirkpatrick 
et al. 2004; Kreuger et al. 2004; Franch-Marro et al. 2005); this biphasic activity of Dlp 
serves to reduce the morphogen gradient. Various models have been proposed to 
explain Dlp’s biphasic activity. An early model focused on proteolytic cleavage of Dlp by 
Notum, an α/β-hydrolase expressed at the Wg source, capable of shedding Dlp at its 
GPI anchor and releasing it from the cell surface. One possibility to account for Dlp 
biphasic activity is that Notum cleavage converts Dlp into a short-range Wg antagonist 
(Kreuger et al. 2004). However, in the wing, neither the ectopic expression nor the loss 
of Notum alters Dlp levels, suggesting that the biphasic activity of Dlp is independent of 
Notum (Han et al. 2005; Gallet et al. 2008). A more recent model proposes that Dlp 
mediates transcytosis of Wg from the apical cell surface to the basolateral surface, 
where it is spread to the next distal cell, so that Dlp effectively siphons Wg away from 
regions of high Wg expression toward distal regions (Gallet et al. 2008). Another model, 
based on wing-disc and cell culture studies, suggests that competition between Dlp and 
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Fz2 for binding Wg at the cell surface is responsible for the biphasic activity of Dlp (Yan 
et al. 2009), such that when Wg concentration is high (in short-range signaling), Dlp 
sequesters Wg from Fz2, but when Wg concentration is lower (in long-range signaling), 
Dlp concentrates Wg in the vicinity of Fz2 to promote signaling. 
 
The Fz receptor family 
The soluble Wnt ligands bind to members of the Fz (Fz) family of seven 
transmembrane domain receptors, which have structural similarities to G-protein-
coupled receptors (GPCRs). Biochemical evidence indicates that Wnts bind to the CRD 
of the Fz receptor, and that the affinity of Wnt for Fz is in the low nanomolar range 
(Bhanot et al. 1996; Hsieh et al. 1999). 
The topological similarities of Fz to GPCRs have led to the suggestion that 
heterotrimeric G proteins may be required for Wnt signal transduction, and several 
studies propose a link between G proteins and Wnt pathway activation. Genetic studies 
in Drosophila suggest that Gαo transduces signaling from Fz, and that Gαo interacts 
with the scaffold protein Axin to promote its localization to the plasma membrane 
(Katanaev et al. 2005; Egger-Adam and Katanaev 2009). In cultured mammalian cells, 
depletion of Gαo or Gαq has been shown to inhibit Wnt signaling, possibly via disruption 
of GSK3β–Axin complexes (Liu et al. 2005). More direct evidence for a role of G 
proteins in Wnt pathway activation comes from reconstitution studies indicating that 
Gαo, Gαi2, Gαq, and Gβγ have the capacity to inhibit both β-catenin phosphorylation by 
GSK3 and β-catenin turnover in Xenopus egg extract. In the case of the latter, it was 
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proposed that Gβγ promotes the recruitment of GSK3 to the plasma membrane to 
enhance low-density lipoprotein receptor-related protein 6 (LRP6) phosphorylation and 
activation (Jernigan et al. 2010). Whether heterotrimeric G proteins are bona fide 
mediators of Wnt ligand-mediated signaling, or whether other pathways act through 
them to modulate Wnt signaling, remains unclear. 
 
The co-receptor LRP5/6 
LRP5 and LRP6 are functionally redundant single-pass transmembrane 
receptors that act as co-receptors for Wnt ligands (Pinson et al. 2000; Tamai et al. 
2000; Wehrli et al. 2000). In Drosophila, there is only one family member, Arrow. In 
some assays, LRP6 is more potent than LRP5. There are thought to be no qualitative 
differences in their mechanism of action in mediating Wnt pathway activation, although 
they likely play different roles during development (He et al. 2004; Mi and Johnson 
2005). Biochemical studies of LRP6 indicate that different Wnts may bind to different 
extracellular domains of the LRP5/6 protein (Bourhis et al. 2010). Specifically, the LRP6 
extracellular domain contains four repeating sequences of β-propeller and epidermal 
growth factor-like (βP–E) domains. The crystal structures of the extracellular LRP6 
regions indicate that the βP–E repeats represent two discrete, compact, rigid structures, 
each containing two βP–E pairs. Wnt9b binds the first two βP–E repeats on the 
extracellular domain of LRP6, whereas Wnt3a binds the last two βP–E domains (Ahn et 
al. 2011; Chen et al. 2011; Cheng et al. 2011). 
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Binding of Wnt ligands to Fz and LRP5/6 results in the production of 
phosphatidylinositol (4,5)-bisphosphate (PIP2) (Pan et al. 2008). Increased PIP2 
induces oligomerization and clustering of LRP5/6. Although hydrodynamic studies 
suggest that Fz and LRP6 oligomerize and form clusters of “signalosomes” upon Wnt 
signaling, the in vivo, physiological significance of such events in Wnt pathway 
activation remains to be determined (Cong et al. 2004; Bilić et al. 2007). 
Increased PIP2 also induces recruitment of Axin to LRP5/6. This recruitment may 
be due, in part, to the action of Amer1/WTX (APC membrane recruitment 1 or Wilms 
tumor gene on the X chromosome), a tumor suppressor mutated in Wilms’ tumor that 
binds to Axin, CK1γ, and GSK3. Amer1/WTX is recruited to the plasma membrane in a 
PIP2-dependent manner (Major et al. 2007; Tanneberger et al. 2011). 
The interaction between LRP6 and Axin is critical for activation of the Wnt 
pathway, and the recruitment of Axin and the associated destruction complex to the 
plasma membrane upon Wnt ligand binding initiates a chain of events that leads to the 
phosphorylation of the intracellular domain of LRP5/6. This initial recruitment of Axin to 
LRP6 in a Wnt–Fz-dependent manner is referred to as the “initiation step” of Wnt 
pathway activation (Baig-Lewis et al. 2007). 
The LRP5/6 receptor contains five PPPSPxS motifs on its intracellular domain 
that are required for signal transmission. Each of these five motifs alone can activate 
the Wnt/β-catenin pathway: when transferred to heterologous receptors, the PPPSPxS 
motif is sufficient for pathway activation (Tamai et al. 2004; Zeng et al. 2005). Mutational 
analyses of these motifs indicate that they act in a cooperative manner to mediate 
downstream signaling (MacDonald et al. 2008; Wolf et al. 2008). 
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The predominant kinases involved in PPPSPxS phosphorylation have been 
identified as GSK3 and CK1 (Davidson et al. 2005; Zeng et al. 2005). Wnt binding to 
LRP5/6 has been shown to induce PPPSP phosphorylation by GSK3, and this event 
primes LRP6 for subsequent xS phosphorylation by CK1 (Zeng et al. 2005; Pan et al. 
2008). Another study, however, suggests that CK1 phosphorylates conserved S/T 
clusters outside the PPPSPxS motif, and this phosphorylation primes phosphorylation of 
LRP6 by GSK3 (Davidson et al. 2005). Phosphorylated LRP6 has a high affinity for Axin 
and promotes further recruitment of cytoplasmic Axin-bound GSK3 complexes to the 
cell surface (Mao et al. 2001; Zeng et al. 2008). The recruitment of additional Axin-
bound GSK3 complexes further promotes the phosphorylation of additional LRP5/6 
PPPSP motifs in a positive feedback mechanism and has been referred to as the 
“amplification step” in Wnt pathway activation (Baig-Lewis et al. 2007). Once the Axin-
bound β-catenin destruction complex is recruited by LRP6, the phosphorylated 
cytoplasmic domain of LRP6 is capable of directly inhibiting GSK3 activity, blocking β-
catenin phosphorylation and subsequent ubiquitin-mediated proteasomal degradation 
(Cselenyi et al. 2008; Piao et al. 2008). The capacity of phosphorylated LRP6 to limit 
GSK3 activity by direct inhibition appears to limit the capacity of Axin-bound GSK3 to 
promote further LRP6 phosphorylation (amplification step). It is possible that these two 
events are temporally regulated such that direct inhibition of GSK3 may be blocked 
during the amplification step.  
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The cytoplasmic adaptor Dvl 
Dishevelled (Dvl/Dsh) has long been known to be required genetically in the 
Wnt/β-catenin pathway (Klingensmith et al. 1996). In vertebrates, there are three Dsh 
isoforms encoded by distinct genes (Dvl1–3) (Sussman et al. 1994; Semënov and 
Snyder 1997). Upon Wnt–receptor interaction, Dsh is phosphorylated and recruited to 
the cytoplasmic side of the receptor complex (Yanagawa et al. 1995; Semënov and 
Snyder 1997; Rothbächer et al. 2000). Several studies suggest that physical interaction 
between the Fz receptor and Dvl is important for transduction of the Wnt signal. Dvl 
contains three major domains: the DEP, the PDZ, and the DIX domains. Biochemical 
and structural studies have implicated both the PDZ and the DIX domains of Dsh in 
binding to the Fz receptor (Wong et al. 2000; Wong et al. 2003; Tauriello et al. 2012). 
Dvl phosphorylation upon Wnt signaling appears to be independent of LRP6 activation 
(González-Sancho et al. 2004). Dvl and Axin share DIX domains that can polymerize 
and are required for receptor clustering (Schwarz-Romond et al. 2007). Loss-of-function 
studies show that Dvl acts upstream of LRP6 (Tolwinski et al. 2003). Consistent with 
this observation, Dsh has been shown to bind and activate PI4KIIa and PIP5KI to 
promote the synthesis of PIP2, which is required to promote oligomerization and 
clustering of LRP5/6 (Pan et al. 2008). In overexpression studies in Drosophila and 
Xenopus egg extracts, however, Dsh has been shown to activate β-catenin signaling 
independently of Arrow/LRP6 (Salic et al. 2000). The precise involvement of Dsh in 
receptor activation and Axin recruitment remains to be determined. 
Both the stability and the activity of Dsh appear to be regulated by ubiquitylation. 
Three ubiquitin ligases, NEDL1 and ITCH of the HECT-type ligase and KLHL12 of the 
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Cullin3-type ligase, have been implicated in ubiquitylating Dvl to promote its degradation 
(Miyazaki et al. 2004; Angers et al. 2006; Wei et al. 2012). One study implicates the 
Naked2 protein as a necessary co-factor for Dvl ubiquitylation (Hu et al. 2010). Finally, 
the deubiquitinating enzyme, CYLD (encoded by the familial cylindromatosis tumor 
suppressor gene), has been shown to be a negative regulator of Wnt signaling 
(Tauriello et al. 2010). CYLD was shown to remove a regulatory Lys63-linked ubiquitin 
from Dvl. Thus, ubiquitylation of Dvl via Lys63 linkages appears to be necessary for 
efficient activation of signaling by Dvl. The ubiquitin ligase that mediates Lys63-linked 
ubiquitylation of Dvl, however, is still unknown. 
 
Inhibition of the β-catenin destruction complex 
The β-catenin destruction complex is a macromolecular machine that efficiently 
acts to phosphorylate β-catenin, targeting it for degradation. We will first describe the 
players involved in the formation of the β-catenin destruction complex (Figure 1.1) and 
follow with our current understanding of the behavior of the pathway upon receptor 
activation. 
 
The transcriptional regulator β-catenin 
β-Catenin is the primary effector of Wnt signaling. In the absence of signaling, 
the destruction complex targets β-catenin for ubiquitin-mediated proteasome 
degradation by SCFβ-TRCP, a member of the Skp1-Cullin-F-box (SCF) E3 ubiquitin ligase 
complex. In the presence of signaling, β-catenin is spared destruction and translocates 
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from the cytoplasm to the nucleus to activate signaling. β-Catenin was first identified in 
Drosophila as the segment polarity gene armadillo and also as a component of the 
adherens junction in Xenopus (Nüsslein-Volhard and Wieschaus 1980; McCrea et al. 
1991). The structure of β-catenin consists of a central core of 12 helical 42 amino acid 
armadillo repeats that form a superhelical structure (Huber et al. 1997). Analysis of full-
length β-catenin protein indicates that the N- and C-terminal domains are unstructured 
and form dynamic interactions with the armadillo repeats of the protein (Xing et al. 
2008). Notably, the armadillo repeats form a positively charged groove that mediates 
the interaction of β-catenin with other components of the Wnt pathway [e.g. APC, Axin, 
and T-cell factor (TCF)/LEF] as well as with E-cadherin (Huber et al. 1997; Graham et 
al. 2000; Xing et al. 2003; Xing et al. 2004). 
The cellular factors that coordinate whether nascent β-catenin mediates Wnt 
target gene transcription or plays a structural role in maintaining integrity of the 
adherens junction are not completely understood. A large number of studies using a 
variety of model systems have shown that overexpression of cadherins is sufficient to 
inhibit Wnt target gene transcription and to promote relocalization of β-catenin to the 
membrane (Heasman et al. 1994; Sadot et al. 1998; Gottardi et al. 2001; Stockinger et 
al. 2001). Furthermore, evidence to support potential influence of cadherins on Wnt 
signaling comes from studies demonstrating that proteolytic cleavage of cadherins by 
proteases such as ADAM10 and presenilin-1/γ-secretase is sufficient to release bound 
β-catenin, to increase soluble cytoplasmic β-catenin, and to activate Wnt target gene 
transcription (Marambaud et al. 2002; Maretzky et al. 2005; Reiss et al. 2005). Multiple 
studies in which E-cadherin is knocked down in cells with wild-type Wnt pathway 
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components, however, fail to demonstrate activation of Wnt signaling, suggesting a lack 
of a significant interaction between cadherin-mediated cell adhesion and Wnt signaling, 
compensatory regulation of β-catenin levels with E-cadherin, or that turnover of β-
catenin by the degradation complex in the wild-type situation is capable of 
compensating for the increased flux of β-catenin (Kuphal and Behrens 2006; Herzig et 
al. 2007). Support for the existence of distinct pools of β-catenin comes from a study 
demonstrating that β-catenin can exist as a monomeric or dimeric form bound to α-
catenin (Gottardi and Gumbiner 2004). Biochemical studies indicate that the monomeric 
form preferentially participates in Wnt signaling, whereas the dimeric form preferentially 
binds cadherins. Surprisingly, little is known about the mechanism of β-catenin nuclear 
translocation. 
 
The scaffold protein Axin, the limiting component of the destruction complex 
The scaffold protein Axin is a critical component of the β-catenin destruction 
complex, acting as a limiting negative regulator of Wnt/β-catenin signaling. It was first 
identified as the gene product of the locus fused in mice (Zeng et al. 1997). Axin plays a 
role as a scaffold protein that directly binds to many of the other components of the 
destruction complex and brings them within close proximity to each other (Figure 1.1). 
The sites of interactions have been visualized in co-crystal structures of Axin and APC 
proteins (Spink et al. 2000), Axin and β-catenin (Xing et al. 2003), and Axin and GSK3β 
(Dajani et al. 2003). Studies of Axin in fly embryos suggest that Axin complexes may 
form oligomers in vivo, and that Axin may also act as a cytoplasmic anchor to restrict 
armadillo/β-catenin import into the nucleus (Tolwinski and Wieschaus 2001; Peterson-
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Nedry et al. 2008). Axin was initially found to be present at low concentrations and is the 
limiting component of the β-catenin degradation complex in Xenopus (Lee et al. 2003). 
A long-standing puzzle about Wnt signaling is how it maintains specificity because 
many Wnt components also play biological roles in other cellular processes; for 
example, GSK3 is a node for many types of cell signaling (Forde and Dale 2007). The 
low concentration of Axin has been proposed to isolate the Wnt pathway from affecting 
other intracellular pathways (Lee et al. 2003). The low level of intracellular Axin is due, 
in part, to its ubiquitin-mediated turnover that is promoted by LRP5/6 (Yamamoto et al. 
1999; Cselenyi et al. 2008). Degradation of Axin has been shown to be regulated by 
GSK3 phosphorylation, which inhibits its rate of degradation (Yamamoto et al. 1999). In 
addition, the turnover of Axin requires the tumor suppressor APC, and studies in 
Xenopus egg extract, as well as in flies, suggest that this may represent a mechanism 
to compensate for fluctuations in levels of APC in order to maintain low levels of β-
catenin in cells (Lee et al. 2003). 
Smad ubiquitin regulatory factor 2 (Smurf2) has been shown to be an E3 
ubiquitin ligase that targets Axin for degradation (Kim and Jho 2010). Due to its key role 
in Wnt signaling, it is likely that Axin is tightly regulated. Tankyrase has been shown to 
promote poly ADP-ribosylation (PARsylation) and ubiquitylation and further degradation 
of Axin through the addition of polyADP-ribose moieties onto proteins through 
PARsylation (Huang et al. 2009a). The importance of Axin turnover is demonstrated by 
the identification of tankyrase inhibitors IWR-1 and XAV939 that have been shown to 
potently inhibit Wnt signaling by increasing the steady-state level of Axin (Chen et al. 
2009; Huang et al. 2009). These tankyrase inhibitors prevent PARsylation of Axin and 
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thus reduce Axin turnover. RNF146 has been identified as the polyADP-ribose-directed 
E3 ubiquitin ligase that ubiquitylates Axin (Callow et al. 2011; Zhang et al. 2011). 
RNF146 binds directly to the covalently linked poly(ADP-ribose), targeting Axin for 
degradation and maintaining low steady-state levels of Axin. A deubiquitinating enzyme, 
ubiquitin-specific protease (USP) 34, has been identified to catalyze the deubiquitylation 
of Axin and increase steady-state levels of Axin in cells (Lui et al. 2011). In contrast to 
PARsylation, SUMOylation of Axin at its C-terminus has been shown to confer stability 
by inhibiting Axin ubiquitylation (Kim et al. 2008). Recently, quantitative measurements 
of Axin concentration in a variety of mammalian cells suggest that its levels vary 
significantly to alter the dynamics of Wnt signaling (Tan et al. 2012). Thus, the 
regulation of Axin levels and stability may be a major mechanism by which cells control 
the response to Wnt signals. 
 
The kinase GSK3 
GSK3 is a ubiquitous serine/threonine protein kinase involved in numerous 
cellular processes (Forde and Dale 2007). Antagonizing GSK3 activity is central to all 
models of Wnt signaling mechanisms. The homolog of GSK3 in Drosophila is shaggy, 
aka zeste white 3 (Siegfried et al. 1992). In mammals, there are two distinct genes, α 
and β, that are likely to have redundant functions in the Wnt pathway (Doble et al. 
2007). GSK3 was first identified for its role in the regulation of glucose metabolism, 
targeting muscle glycogen synthase (Embi et al. 1980). GSK3 has both positive and 
negative roles in Wnt signal transduction, which will be described in further detail later in 
this review. GSK3 often recognizes substrates that have been previously 
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phosphorylated (primed), and thus GSK3 is often found to act in concert with other 
kinases. β-Catenin phosphorylation by GSK3 (at Ser33, Ser37, and Thr41) leads to its 
ubiquitin-mediated degradation (Peifer et al. 1994; Yost et al. 1996). The crystal 
structure of GSKβ has been solved and conforms to a typical protein kinase bilobed 
structure topology consisting of an amino-terminal β-sheet domain linked to a carboxy-
terminal α-helical domain. Similar to other activated kinases, the structure of 
unphosphorylated GSK3β shows an activation loop that is responsible for its unique 
priming mechanism (Haar et al. 2001). Furthermore, phosphorylation of Ser9, which has 
been shown to inhibit GSK3 activity, is predicted to act in an auto-inhibitory fashion by 
blocking access to the catalytic site (Dajani et al. 2001). In addition to β-catenin, other 
major Wnt pathway substrates of GSK3 include APC, Axin, and LRP6 (Rubinfeld et al. 
1996; Willert et al. 1999; Zeng et al. 2005). 
 
The kinase CK1α 
The CK1 family of kinases is comprised of a group of serine/threonine kinases 
encoded by seven distinct genes in mammals (α, β, γ1, γ2, γ3, δ, and ε; although β was 
identified in bovine and has not been found in humans) (Knippschild et al. 2005). As 
with GSK3, CK1 is a widely-expressed family of kinases with a large number of 
substrates. All CK1 members have highly similar catalytic domains, but differ 
significantly in both the length and the sequence of their C-terminal non-catalytic 
domains. CK1α, with its short (~24 amino acid) C-terminal domain, appears to be an 
outlier compared with the other family members, which have much longer C-terminal 
tails (~200 amino acids). CK1α, γ, δ, and ε have been implicated in positively regulating 
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the Wnt pathway by phosphorylating Dsh, LRP5, TCF/LEF, and Axin (Peters et al. 
1999; Kishida et al. 2001; Cong et al. 2004; Zeng et al. 2005). In contrast, CK1 family 
members have also been implicated as negative regulators of the Wnt pathway by 
phosphorylating β-catenin, APC, Axin, and TCF/LEF (Kishida et al. 2001; Gao et al. 
2002; Hämmerlein et al. 2005). CK1α has been proposed to be the in vivo priming 
kinase for GSK3 and phosphorylates β-catenin at Ser45 (Liu et al. 2002). The activation 
of CK1α has emerged as a potential therapeutic drug target, and a recent study 
reported that the antihelminthic drug, pyrvinium, inhibits Wnt signaling by activating 
CK1α to enhance β-catenin phosphorylation and degradation (Thorne et al. 2010). 
 
β-catenin degradation cycle 
The ubiquitous expression of β-catenin and other pathway members suggests 
that all metazoan cells express the β-catenin destruction complex. Although commonly 
described as having cytoplasmic localization, the core components can also be found in 
the nucleus where the β-catenin destruction complex is likely to reside and function 
(Cong and Varmus 2004; Wiechens et al. 2004; Sierra et al. 2006). This machine is in a 
constitutively active state and contains a number of enzymes that target β-catenin for 
degradation. Thus, in the absence of a Wnt signal, β-catenin is caught in a cycle of 
synthesis followed by rapid destruction. Axin is the scaffold protein that nucleates the 
formation of the β-catenin destruction complex. It binds with high affinity to the two 
kinases GSK3 and CK1α. A well-defined α-helix in the central portion of Axin anchors 
GSK3, whereas the site of CK1 binding has been mapped to a more C-terminal region 
of Axin (Dajani et al. 2003; Sobrado et al. 2005). APC binds the RGS domain of Axin, 
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an N-terminal region that has structural homology to domains found in regulators of G-
protein signaling (Spink et al. 2000). β-Catenin enters the complex by binding both 15 
amino acid repeats of APC and a single α-helix on Axin on the C-terminal side of the 
GSK3 binding site. The exact order and kinetics of binding are unknown, and it is 
unclear whether this binding is ordered or stochastic (Lee et al. 2003). 
Evidence suggests that phosphorylation of Axin, likely by GSK3, increases its 
affinity for β-catenin (Willert et al. 1999). Upon binding to Axin, the N-terminal region of 
β-catenin becomes positioned for rapid phosphorylation by CK1 at serine 45. This 
creates a priming site for subsequent and successive phosphorylation of β-catenin by 
GSK3 at Thre41, Ser37, and Ser33 (Amit et al. 2002; Liu et al. 2002). Twenty amino 
acid repeats on APC are also phosphorylated by CK1 and GSK3 (Ha et al. 2004). This 
phosphorylation increases the affinity of the 20 amino acid repeats for β-catenin by 140-
fold and competes β-catenin off of the α-helix binding site on Axin. Based on these 
observations, it has been proposed that APC phosphorylation triggers β-catenin 
removal from Axin, allowing a new β-catenin species to enter the destruction complex 
(Kimelman and Xu 2006). The action of APC is also thought to prevent the action of the 
phosphatase, PP2A, from acting on the phosphorylated β-catenin (Su et al. 2008). Once 
β-catenin is phosphorylated at Ser33 and Ser37, a destruction consensus sequence is 
recognized by β-TRCP, a specificity subunit of the SCF ubiquitin ligase (Jiang and 
Struhl 1998; Kitagawa et al. 1999; Liu et al. 1999). Binding of SCFβ-TRCP to β-catenin 
catalyzes its polyubiquitylation (via K48 linkages) and subsequent degradation through 
the proteasome. These events ensure that newly synthesized, free cytosolic levels of β-
catenin are kept below the threshold necessary for gene regulation.  
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Pathway behavior on activation 
Elevation of β-catenin levels in response to the presence of Wnt is a hallmark of 
the Wnt/β-catenin pathway. The precise mechanism of destruction complex inhibition is 
under intense investigation and a number of proposed mechanisms exist. At the core of 
all the current models is the inhibition of GSK3 anti-catenin activity. This has been 
proposed to arise through several distinct mechanisms: (1) dissociation of components 
of the β-catenin destruction complex, (2) phosphorylation of GSK3 at Ser9, which 
inhibits its activity, (3) LRP6 binding and direct inhibition of GSK3 activity against β-
catenin, and (4) Axin degradation upon activation of signaling, which prevents formation 
of the destruction complex necessary for GSK3 to phosphorylate β-catenin. We discuss 
these models individually below. 
Several studies have described Axin–GSK3 dissociation upon signaling (Liu et al. 
2002; Luo et al. 2007). Early studies seem to suggest that Dvl recruits GSK3 binding 
protein (GBP) to Axin where GSK3 is directly inhibited and dissociates from Axin (Yost 
et al. 1998; Farr et al. 2000). One caveat to these studies is the apparent lack of 
requirement for GBP in Wnt signaling in Drosophila and mice. Drosophila does not have 
a GBP ortholog, and genetic knockout studies in mice show no requirement for GBP in 
development or Wnt signaling (van Amerongen et al. 2005). In contrast to these studies, 
other studies have shown that the complex remains intact and localizes to the Fz/LRP6 
co-receptors rapidly after Wnt stimulation (Mao et al. 2001; Bilić et al. 2007). 
GSK3α/β is phosphorylated at Ser9 and Ser21, and when phosphorylated at 
these sites, kinase activity is greatly reduced (Sutherland et al. 1993; Cross et al. 1995). 
Wnt-induced stimulation of Ser9/21 phosphorylation has been speculated about by 
27 
 
several groups (Ding et al. 2000; Yokoyama and Malbon 2007). However, studies in 
mice in which non-phosphorylatable forms of GSK3α/β were knocked-in produced 
animals with no developmental defects and no observable perturbation in Wnt pathway 
activation (McManus et al. 2005). 
A number of mammalian cell culture and biochemical studies suggest that the β-
catenin destruction complex moves to the cell surface upon Wnt stimulation, and this 
migration is followed by the direct inhibition of GSK3 by LRP6 (Yamamoto et al. 2006; 
Bilić et al. 2007; Cselenyi et al. 2008). The collective evidence from these studies 
suggests a mechanism in which ligand-stimulated LRP6 phosphorylation by GSK3 and 
CK1 creates a docking site for Axin. This phosphorylation event in turn recruits the 
Axin–GSK3 complex to the receptor. Recruitment of Axin–GSK3 to phosphorylated 
LRP6 has been proposed to be facilitated in part by Dsh, which binds directly to the Fz 
receptor and Axin (Schwarz-Romond et al. 2007). A problem for this model, however, is 
the requirement for GSK3 to phosphorylate the PPPSPxS motifs on LRP5/6 to create 
docking sites for Axin–GSK3 (amplification step) and the fact that phosphorylated 
PPPSPxS motifs can directly inhibit GSK3 activity, further limiting LRP6 
phosphorylation. High-resolution structural data are essential to clarify this model and to 
explain how PPPSPxS motifs are sufficient for both Axin docking and GSK3 inhibition. 
A compendium of studies from cell culture, Xenopus embryos and egg extracts, 
and Drosophila suggest that a conserved and critical event is the degradation of Axin 
upon Wnt signaling (Yamamoto et al. 1999; Tolwinski et al. 2003; Cselenyi et al. 2008). 
Because Axin is a concentration-limiting factor, regulation of Axin stability is likely to 
have a dramatic effect on signaling (Lee et al. 2003). Genetic studies in Drosophila 
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designed to elucidate the requirement of Axin regulation show that flies genetically null 
for GSK3 have elevated levels of β-catenin as expected, yet unexpectedly they still 
have near wild-type Wg-based embryonic patterning that is dependent on dynamic 
levels of Axin. These results indicate that regulation of Axin stability is sufficient to 
pattern the embryo, as β-catenin nuclear translocation only occurs when Axin levels are 
low, and Axin may act as a cytoplasmic anchor to regulate β-catenin-mediated 
transcription (Tolwinski et al. 2003). Other work has shown that Axin degradation 
appears to lag behind β-catenin stabilization and is not necessary for β-catenin 
stabilization (Willert et al. 1999; Hino et al. 2005; Cselenyi et al. 2008). These studies 
promote the model that the block in β-catenin destruction that occurs upon Wnt 
signaling does not require Axin turnover, and that degradation of Axin is a distinct event 
that may modulate the character of the response. 
 
Activation of a Wnt-specific nuclear transcriptional complex 
Nuclear translocation of β-catenin 
β-catenin is normally constitutively transcribed and translated. Thus, a signal-
induced block in proteolysis leads to rapid rise in cytosolic β-catenin protein levels upon 
receptor activation. In addition to increased cytosolic accumulation, β-catenin also 
accumulates in the nucleus. Remarkably, studies indicate that it is not the absolute 
increase in concentration of β-catenin that results in activation of a Wnt transcriptional 
program (Goentoro and Kirschner 2009). Rather, it is the relative fold change (~2 ×) in 
the concentration of β-catenin that is recognized by the Wnt transcriptional machinery. 
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Such a mechanism is expected to minimize cell–cell variation caused by fluctuations in 
the basal level of β-catenin as well as allowing for activation of the transcriptional 
program when the signal is sufficiently elevated in proportion to the background noise 
(Goentoro et al. 2009). 
β-catenin does not contain any recognizable nuclear localization signal (NLS) or 
nuclear export signal (NES). Nuclear accumulation of β-catenin has been attributed to 
its cytoplasmic retention, nuclear retention, and nuclear export. Nuclear entry of β-
catenin is thought to be independent of classic import factors (e.g. RanGTPase and 
importins) (Fagotto et al. 1998; Yokoya et al. 1999). The armadillo repeats of β-catenin, 
however, are structurally related to importin-β HEAT repeats and may interact directly 
with the nuclear pore complex during nuclear entry (Kutay et al. 1997; Malik et al. 1997). 
Surprisingly, deletion of β-catenin armadillo repeats 3–6 in Drosophila, which 
presumably disrupts binding to major cytoplasmic Wnt components, results in 
constitutive nuclear localization of the armadillo/β-catenin mutant (Orsulic and Peifer 
1996). Based on this result, it has been suggested that β-catenin is normally regulated 
by its cytoplasmic retention. Consistent with this data, both cadherins and Axin have 
been shown to sequester β-catenin in the plasma membrane and cytoplasm, 
respectively (Heasman et al. 1994; Sadot et al. 1998; Gottardi et al. 2001; Tolwinski and 
Wieschaus 2001). The nuclear proteins TCF, Pygopus, and BCL9 (described below) 
have been proposed to similarly act as anchors for β-catenin in the nucleus (Townsley 
et al. 2004; Krieghoff et al. 2006). It has been proposed that nuclear export of β-catenin 
may play a critical role in Wnt signaling, and Axin, APC, and RanBP3 have been 
implicated in regulating the export of β-catenin from the nucleus (Henderson and 
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Fagotto 2002; Cong and Varmus 2004). Finally, Rac1 GTPase and Jun N-terminal 
kinase 2 (JNK2) have also been shown to promote β-catenin nuclear localization upon 
Wnt signaling, although the mechanism by which this is accomplished is unclear (Wu et 
al. 2008). 
 
β-catenin-mediated gene transcription 
Wnt-induced nuclear β-catenin accumulation leads to an interaction with the 
TCF/LEF family of DNA-bound transcription factors that are critical for Wnt-mediated 
gene regulation (Behrens et al. 1996; Molenaar et al. 1996). Invertebrates appear to 
have only one TCF gene, whereas mammals have four: TCF1, LEF1, TCF3, and TCF4. 
In the absence of β-catenin, TCF interacts with the co-repressor Groucho/transducin-
like enhancer (Gro/TLE1–3 in vertebrates) to repress gene transcription. TCF binds at 
the DNA consensus sequence CCTTTGWW (W can be either T or A), termed the Wnt-
responsive element (WRE). It has been predicted that there are greater than 6000 high-
confidence WREs in at least one studied colorectal cancer cell line, and these WREs 
collectively regulate 300–400 genes (Hatzis et al. 2008). 
Several studies suggest that TCF proteins are phosphorylated to regulate Wnt 
signaling. CK1 has been shown to phosphorylate TCF to positively and negatively 
regulate its interaction with β-catenin (Lee et al. 2001; Hämmerlein et al. 2005). The 
Nemo-like kinase (NLK) has been shown to phosphorylate TCF and inhibit Wnt 
signaling by reducing the affinity of β-catenin–TCF for DNA (Ishitani et al. 2003; Smit et 
al. 2004). Finally, phosphorylation of LEF-1, TCF4, and TCF3 by the homeodomain-
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interacting protein kinase 2 has been shown to promote their dissociation from Wnt 
target gene promoter (Hikasa et al. 2010; Hikasa and Sokol 2011). TCF proteins are 
also modified by ubiquitylation. The NLK-associated RING finger protein promotes the 
ubiquitylation of TCF/LEF, targeting it for degradation in a manner dependent on NLK 
activity (Yamada et al. 2006). Similarly, the deubiquitinase USP4, which deubiquitylates 
K48 and K63 ubiquitin linkages, has been shown to act on TCF4 to inhibit Wnt signaling 
(Zhao et al. 2009). In the canonical model of Wnt target gene activation, displacement 
of Gro/TLE by β-catenin converts TCF/LEF into a transcriptional activator. The X-linked 
inhibitor of apoptosis has been shown to monoubiquitinate Gro/TLE, decreasing its 
affinity for TCF/LEF and allowing for unrestricted binding of β-catenin to TCF/LEF 
(Hanson et al. 2012). 
Two notable nuclear co-factors found in Drosophila and vertebrates, Pygopus 
(Pygo) and BCL9, have been shown to facilitate Wnt pathway-mediated transcription 
(Belenkaya et al. 2002; Thompson et al. 2002). BCL9 binds and bridges β-catenin with 
the Pygo protein. Pygo has been shown to bind the multiprotein transcriptional co-
activator mediator complex and contains a plant homology domain that interacts with 
dimethylated histone 3 lysine 4, an indicator of transcriptional activation (Fiedler et al. 
2008). Studies in Drosophila indicate that TCF, β-catenin, BCL9, and Pygo represent a 
core transcriptional complex that is necessary for Wnt-mediated gene transcription. In 
mammals, the situation is more complex, and there appears to be functional 
redundancy and cell type-specific roles for BCL9 and Pygo (Schwab et al. 2007; 
Sustmann et al. 2008). 
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It is important to note an often-underappreciated role for TCF/β-catenin signaling 
in transcriptional repression. Studies have shown a number of potential mechanisms of 
repression, including competition of TCF/β-catenin with transcriptional activators, 
recruitment of co-repressors to WREs, or TCF binding to a novel consensus sequence 
that specifically mediates repression (Jamora et al. 2003; Theisen et al. 2007; 
Blauwkamp et al. 2008). In addition, there are multiple studies showing that many DNA-
binding transcription factors (e.g. Smad3, AP-1, RXR, and Kaiso) bind to β-catenin to 
activate or repress Wnt/β-catenin target genes. In light of the large number of TCF 
binding sites and numerous transcriptional co-regulators, it is clear that the Wnt/β-
catenin gene expression program is vast and induces dramatic changes in the 
physiological state of the cell, many of which are still not well understood (Cadigan 
2012). Thus, Wnt signaling leads to a transcriptional program that includes 
downregulation and upregulation, rather than to simply transcriptional activation. 
 
The scaffold protein APC 
APC is a scaffold protein consisting of 2843 amino acids with a mass of 
approximately 310 kDa, and it acts as a negative regulator of Wnt/β-catenin signaling. 
Vogelstein and colleagues first identified the gene in 1991 as the site of a mutation 
found in FAP, a familial form of colon cancer (Kinzler et al. 1991; Nishisho et al. 1991). 
APC plays diverse roles in cellular functions, including Wnt signaling, migration, mitotic 
spindle alignment, and apoptosis, which are likely carried out through different APC 
subpopulations (Faux et al. 2008). The C-terminal third of APC contains a region 
involved in microtubule binding that interacts with the proteins EB1 and Discs large (Su 
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et al. 1995; Matsumine et al. 1996). These regions have been demonstrated to be 
involved in microtubule dynamics in mitosis and cell migration and are thought to be 
independent of the role of APC in Wnt signaling (Näthke et al. 1996). The connection 
between APC and Wnt signaling was identified in a series of studies that showed that 
APC binds to β-catenin, and that mutations in APC caused elevated levels of β-catenin 
in cancer cells (Rubinfeld et al. 1993; Su et al. 1993). APC binds β-catenin, GSK3, and 
Axin in several regions within the central portion of the protein (Rubinfeld et al. 1996; 
Ikeda et al. 1998; Fagotto 1999). Despite numerous studies published on the function of 
APC, a clear mechanistic picture of the role of APC in regulating the Wnt pathway 
remains elusive. Indeed, loss of APC leading to elevated β-catenin levels and activation 
of the Wnt pathway can be overcome by overexpression of Axin, which is the limiting 
component of the β-catenin destruction complex (Lee et al. 2003). Furthermore, 
overexpression of an Axin mutant lacking its APC binding domain (RGS) is capable of 
promoting β-catenin degradation and inhibiting Wnt signaling to a similar extent as 
overexpression of wild-type Axin (Hart et al. 1998). 
How APC acts as a negative regulator of Wnt/β-catenin signaling is something of 
a mystery. Several models have been proposed, including (1) exporting β-catenin from 
the nucleus (Hamada and Bienz 2004), (2) repressing Wnt target genes (Sierra et al. 
2006), (3) retaining β-catenin in the cytoplasm (Tolwinski and Wieschaus 2001), (4) 
targeting the β-catenin destruction complex to the cell cortex, where its E3 ubiquitin 
ligase (SCFβ-TRCP) resides (Näthke et al. 1996; McCartney et al. 1999), (5) coordinating 
the phosphorylation and release of β-catenin from the destruction complex to allow its 
ubiquitylation (Kimelman and Xu 2006), (6) blocking dephosphorylation of β-catenin by 
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protein phosphatase 2A (PP2A) (Su et al. 2008), and (7) shielding the β-catenin 
degradation complex from the inhibitory action of Dvl (Mendoza-Topaz et al. 2011). 
None of the proposed models for the role of APC in the Wnt pathway are 
mutually exclusive, although the most compelling experimental evidence (4–6) strongly 
supports APC’s role in negatively regulating steady-state levels of cytoplasmic β-
catenin. It is likely that APC, similar to other components of the Wnt pathway (e.g. 
GSK3 and CK1), may participate in multiple events in the Wnt signaling pathway. 
Several kinases, including CK1, protein kinase A (PKA), and GSK3, have been 
shown to phosphorylate APC (Rubinfeld et al. 1996; Morin et al. 1997). Phosphorylation 
of APC by GSK3 was shown to enhance binding of β-catenin by APC (Salic et al. 2000). 
In addition to phosphorylation, the APC protein is ubiquitinated. In cells, APC is 
stabilized by the COP9 signalosome-associated deubiquitinase, USP15, which binds to 
the β-catenin degradation complex (Huang et al. 2009). The deubiquitinase Trabid, 
which removes K63-linked regulatory ubiquitylation chains from APC, has been 
identified as a positive regulator of Wnt signaling (Tran et al. 2008). Although it is not 
clear if APC is the sole target of Trabid, this finding is consistent with the suggestion 
that K63-linked ubiquitylation of APC antagonizes Wnt signaling, presumably by 
potentiating APC activity. The E3 ligase that mediates ubiquitylation of APC and the 
exact mechanism by which these K63-linked ubiquitin chains regulate APC activity are 
unknown. 
 
 
35 
 
The interaction between cells and their extracellular environment 
The outer layer of the plasma membrane is the surface from which cells 
communicate with their environment. Among the many membrane components, there 
are membrane receptors which are required to activate signaling pathways in response 
to environmental perturbations. In order to maintain homeostasis, cells often control the 
abundance of receptors at the surface of the plasma membrane via their internalization 
(thereby removing them from participation in signaling) through a process called 
“endocytosis” (Doherty and McMahon 2009; Sorkin and von Zastrow 2009). 
 Over 100 years ago, Ilya Metchnikoff made the first observation of cell 
internalization. In 1882, he reported that specific cells used vesicles to engulf and 
degrade pathogens. He called this process “phagocytosis” (Tauber 2003). In 1931, 
Warren Lewis observed that cells used similar vesicles to uptake fluids in a process he 
described as “pinocytosis”. In the following years, Christian de Duve discovered 
lysosomes and while studying their function coined the term “endocytosis” (Sabatini and 
Adesnik 2013). The development of electron microscopy (EM) allowed for further 
discoveries in the process of endocytosis and greatly advanced the field. In 1953, 
George Palade identified “cave-like” invaginations of the cell membrane, and named 
them “caveolae” (Latin for little caves). For their work, both de Duve and Palade 
received the Nobel Prize in 1974 (Nassoy and Lamaze 2012). Finally, in 1975 Joseph 
Goldstein, Michael Brown, and Richard Anderson showed that the low-density 
lipoprotein (LDL), binds to a cell surface receptor leading to formation of “coated pits” 
(Goldstein and Brown 2009). These pits are then internalized and the LDL receptor is 
endocytosed. Goldstein and Brown coined this process “receptor-mediated endocytosis” 
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and were awarded the Nobel Prize in 1985. During the same year, Barbara Pearse 
isolated and identified the major component of those pits as clathrin, giving rise to the 
term “clathrin-mediated endocytosis” (CME) (Robinson 2015). 
 
Clathrin mediated endocytosis 
Most of the early work performed to understand the process of endocytosis 
focused on CME. The main player involved in CME is the clathrin protein. Clathrin is a 
trimer composed of three 190kDa heavy chains bound to a 25kDa light chain which, 
together assemble a cage-like structure and form invaginations on the cytoplasmic side 
of the plasma membrane called clathrin-coated pits (CCP) (Figure 1.3) (Kirchhausen 
2000; Takei and Haucke 2001; Schütze et al. 2008). Several adaptor proteins such as 
AP-1 through AP-5, ARH, Dab2, Fe65, AP180, Epsin, and Snx17 interact with clathrin 
and their specific cargo proteins (Traub and Bonifacino 2013). Of these clathrin-
associated proteins, the best studied are the AP family of adaptors. AP-2 is the major 
AP family member required for trafficking at the plasma membrane and plays a pivotal 
role in clathrin-mediated endocytosis. AP-2 links clathrin to the membrane and 
coordinates the assembly of the clathrin coat. The AP-2 complex comprises two large 
subunits,  and 2, and two smaller subunits, 2 and 2 (Takei and Haucke 2001). The 
 subunit targets the AP-2 complex to the membrane by binding to the phospholipids, 
phosphatidyl inositol-4,5-bisphosphate (PIP2) and phosphatidyl inositol-3,4,5-
trisphosphate (PIP3) (Chang et al. 1993; Gaidarov et al. 1996; Gaidarov and Keen 
1999). The 2 and 2 subunits recognize specific motifs on the cytoplasmic domain of 
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transmembrane receptors and provide cargo specificity to the CCPs (Ohno et al. 1995; 
Nesterov et al. 1999).  
In CME, AP-2 associates with PIP2 at the plasma membrane and recruits clathrin 
molecules resulting in the formation of clathrin-coated buds. These clathrin-coated buds 
eventually form clathrin-coated vesicles (CCV), which are irreversibly released into the 
cytoplasm by a large GTPase called Dynamin. Inhibition of dynamin function by small 
molecules or a kinase-dead form of Dynamin prevents release of CCV and blocks 
endocytosis (Damke et al. 1994; Doherty and McMahon 2009; Kirchhausen et al. 2014). 
Clathrin is released from vesicles by Auxilin and Hsc70, and naked vesicles are 
transported (along with their cargo) to their designated cellular compartment (Doherty 
and McMahon 2009). Internalization of a variety of receptors are regulated by CME and 
include G-protein coupled receptors (GPCRs), the transferrin receptor, and the LDL 
receptor. Thus, CME plays a role in regulating homeostasis of a diverse number of 
receptors.  
 
Caveolin-mediated endocytosis  
Among the many clathrin-independent endocytic pathways, endocytosis by caveolae is 
the best characterized. Caveolae are pits 60-80 nm in diameter in the plasma 
membrane that are enriched for caveolins, sphingolipids, and cholesterol (Figure 1.3). 
Three caveolin isoforms are expressed in mammals, and expression of each one is cell 
type dependent. Caveolin-1 (Cav1, the most common isoform) and caveolin-2 (Cav2) 
are expressed in non-muscle cells, whereas caveolin-3 (Cav3) is present only in muscle  
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Figure 1.3. Schematics of major endocytic pathways in the cell.  
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cells (Nassoy and Lamaze 2012). Cav1 and Cav3 are required for caveolae formation 
(Drab et al. 2001; Galbiati et al. 2001). The requirement of Cav2 in caveolae formation 
is not clear because loss of Cav2 function has no observable effect in vivo (Razani et al. 
2002; Sowa et al. 2003). All caveolin proteins encode cytoplasmic N- and C-terminal 
domains connected by an intramembrane hairpin. Caveolin palmitoylation at Cys133, 
Cys145, and Cys156 facilitate their binding to the plasma membrane (Dietzen et al. 
1995; Parton and Simons 2007). Caveolins oligomerize and interact with cholesterol-
rich domains in the plasma membrane known as lipid rafts (Murata et al. 1995). 
Interaction with lipid rafts is critical for caveolae formation, and it has been shown that 
cholesterol depletion increases Cav1 motility and disrupts the function of caveolae 
(Rothberg et al. 1992). 
Once caveolae are released from the plasma membrane by the GTPase, 
Dynamin (Henley et al. 1998), they can either fuse with the early endosome in a 
process mediated by Rab5, or fuse with a large non-endosomal organelle (caveosome) 
in a Rab5-independent manner. The caveolar vesicles are then recycled back to the 
membrane for reuse (Razani et al. 2002; Pelkmans et al. 2004). Two early studies 
identified a large number of proteins involved in signal transduction within caveolae 
(Sargiacomo et al. 1993; Lisanti et al. 1994). This observation, led to formation of the 
“caveolae/raft hypothesis”, that proposed that localization of signaling molecules in a 
compartment could facilitate cross-talk between signaling pathways. Although the 
molecules found in caveolae do not exhibit a common feature that specifically targets 
them to caveolae, they all undergo lipid modification. Indeed, many signal transduction 
proteins found in caveolae (e.g., the Epidermal Growth Factor Receptor (EGFR), H-
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Ras, Src family of tyrosine kinases, and  subunit of heterotrimeric G-proteins) have 
one or more myristoyl, palmitoyl, or prenyl groups (Platta and Stenmark 2011). 
 
Endocytosis and signaling 
Although receptor internalization is often thought of being associated with a 
decrease in sensitivity to stimulus by controlling the number of receptors available at the 
plasma membrane, it also promotes signal propagation within the cell. Upon their 
activation, receptors typically undergo post-translational modifications, which promote 
recruitment of proteins required for signaling and/or endocytosis (Sorkin and von 
Zastrow 2009). Internalized receptors are subsequently sorted to specific compartments 
depending on the requirement of the cell. For example, if decreased signaling is 
needed, receptors are sorted to late endosomes and lysosomes for degradation. If 
further signaling is required, receptors are shuttled back to the plasma membrane 
(Platta and Stenmark 2011).  
The prevailing model for receptor endocytosis proposes that receptors of 
essentially all major signaling pathways undergo CME. On other hand, certain receptors 
(e.g., some GPCRs, Transforming Growth Factor  (TGF) receptors, Wnt receptors, 
and Notch) undergo clathrin-independent endocytosis such as caveolin-mediated 
endocytosis (Sorkin and von Zastrow 2009). The concentration of ligands (e.g., EGF) at 
the plasma membrane modulate whether the signaling is regulated by clathrin-or 
caveolin-mediated endocytosis (Platta and Stenmark 2011). Because both clathrin- and 
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caveolin-mediated endocytosis have a direct impact on the qualitative behavior of the 
output, preference for one or the other may depend on the type of response required. 
Upon CME, receptors are sorted to early endosomes, where they continue to 
interact with downstream molecules to propagate the response in order to maintain 
proper signal duration and intensity (Sigismund et al. 2008). EGFR has been the most 
extensively studied and exemplifies this mode of action. Stimulation of cells with EGF, 
result in rapid clustering of EGFR in CCPs and CCVs. Recruitment of downstream 
effectors such as GRB2, SH2 domain-containing transforming protein (SHC), Ras, and 
MAP kinase, occur at the plasma membrane and maintain their interactions in early 
endosomes (Vieira et al. 1996; Sorkin and von Zastrow 2009). 
Some signaling complexes are exclusively sorted into early endosomes where 
the signaling output is modulated. The lipid composition of the early endosomal 
membrane, which is rich in phosphatidylinositol-3-phosphate (PIP3), define their 
specificity (Funderburk et al. 2010). This phenomenon occurs in TGFsignaling where 
the TGFreceptor associates with the PIP3-binding proteins, SARA and endofin. SARA 
binds to internalized TGF-receptor and SMAD2 and facilitates the phosphorylation of 
the latter. Phosphorylated SMAD2 interacts with SMAD4, and the resultant complex 
translocates to the nucleus to promote gene transcription. Similarly, endofin interacts 
with TGF-receptor to promote assembly of the SMAD2-SMAD4 complex (Chen et al. 
2007). 
Change in phospholipid composition in early endosomes can also result in the 
disassembly of protein complexes. In the case of the Toll-like receptor 4 (TLR4), 
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activated TLR4 interacts with the PIP2-associated protein TIRAP and MyD88. After 
translocation to the endosome, the low concentration of PIP2 results in complex 
dissociation. TLR4 is subsequently free to associate with TRAM and TRIF, thereby 
activating endosome-specific TLR4 signaling to promote the secretion of type I 
interferons (Platta and Stenmark 2011).  
Recycling of receptors from the early endosome back to the plasma membrane 
can modulate the response of signaling pathways. For example, the β2-adrenergic 
receptor is sorted into early endosomes that are shuttled back to the plasma membrane 
following a fast recycling route mediated by Rab4-positive endosomes. Alternatively, 
receptors are transported to recycling endosomes in a Rab11-dependent manner to 
follow a slow recycling pathway (Puthenveedu et al. 2010). In the case of the transferrin 
receptor, export to the plasma membrane can occur via bulk membrane recycling or 
sequence-dependent recycling, which relies on local actin polymerization. Studies 
indicate that the β2-adrenergic receptor is also recycled by this mechanism (Stenmark 
2009; Puthenveedu et al. 2010). 
Finally, receptors transported to late endosomes or multivesicular endosomes 
(MVE, also known as multivesicular bodies (MVB)) are usually targeted to lysosomes 
for degradation. One well-studied example is EGFR, which is ubiquitylated and targeted 
for lysosomal degradation, thereby, downregulating the EGFR signaling cascade (Wiley 
et al. 1985; Renfrew and Hubbard 1991). MVEs can also promote specific signaling 
events. For instance, the adaptors p14 and MP1 recruit MEK1 to MVEs in order to 
propagate ERK signaling (Teis et al. 2006). It is clear that signal transduction relies on 
multiple cellular mechanisms to effectively activate and regulate downstream effectors. 
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For the Wnt pathway, there is a growing body of evidence supporting the necessary role 
of endocytosis in Wnt signal transduction although our knowledge of the role of 
endocytosis in Wnt signaling is currently limited.  
 
Regulation of the Wnt pathway by endocytosis 
 The first evidence of the role of endocytosis in Wnt signaling was the observation 
that Wg (Drosophila Wnt) localizes by electron microscopy in receiving cells in small 
vesicles as well as multivesicular bodies (MVBs) (van den Heuvel et al. 1989). MVBs 
are the last compartment receptors are sorted into prior to lysosomal degradation. 
Furthermore, shibire mutants, the Drosophila homolog of dynamin, resulted in 
accumulation of Wg at the extracellular surface of the plasma membrane (Bejsovec and 
Wieschaus 1995; Strigini and Cohen 2000). Consistent with these findings, the co-
receptors Arrow and Fz mediate Wg internalization in Drosophila (Rives et al. 2006).  
 Initial studies suggested that Wg internalization resulted in downregulation of the 
Wnt pathway in Drosophila embryos (Dubois et al. 2001). Thus, blocking internalization 
should enhance Wnt signaling. However, further evidence showed that inhibition of 
endocytosis by loss of dynamin or Rab5 function not only affected Wg endocytosis, but 
also inhibited Wg signaling (Seto and Bellen 2006). These results were confirmed in 
mammalian cells where loss of dynamin function and inhibition of clathrin- or caveolin-
mediated endocytosis blocked Wnt activation in the presence of Wnt ligands (Blitzer 
and Nusse 2006; Yamamoto et al. 2006). The contradicting evidence highlights the 
complexity behind the regulation of membrane components of the Wnt pathway. 
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 Both clathrin and caveolin have been proposed to mediate LRP6 internalization. 
LRP6 interacts with clathrin as well as the adaptor protein AP-2 (as assessed by 
sucrose density gradient experiments). The interaction between LRP6 and AP-2 appear 
to be strengthened by Wnt ligands. Reports show that the number of clathrin clusters 
around LRP6 at the cell membrane significantly increases upon Wnt3a treatment (Kim 
et al. 2013). Also, Wnt3a promotes PIP2 formation leading to LRP6 phosphorylation and 
AP-2 recruitment (Pan et al. 2008). Furthermore, the  subunit of AP-2 has been shown 
to interact with Dvl (Yu et al. 2007). These studies agree with a recently proposed 
model in which LRP6 resides in nascent clathrin-coated pits, and, in the presence of 
Wnt3a, the Wnt signalosome is assembled in CCV in a process mediated by AP-2 
(Gammons et al. 2016). 
In contrast to the clathrin-based model, another model proposes that LRP6 is 
internalized by caveolae upon Wnt activation. In this model, LRP6 resides in lipid rafts 
that interact with caveolin in the presence of Wnt3a, allowing for Axin recruitment and -
catenin accumulation. LRP6 subsequently recycles back to the plasma membrane via 
Rab5- and Rab11-positive vesicles (Yamamoto et al. 2006). Interestingly, LRP6 
phosphorylation still occurs upon dynamin inhibition (blocks LRP6 internalization) in the 
presence of Wnt, and LRP6 is internalized in the absence of Wnt. In the case of the 
latter, LRP6 phosphorylation required the presence of Wnt ligand. -catenin 
accumulation, however, required both LRP6 phosphorylation and internalization, 
suggesting that caveolin-mediated endocytosis prevent spontaneous activation of the 
Wnt pathway. The same investigators showed that the Wnt antagonist, DKK1, promotes 
CME of LRP6, suggesting that different endocytic pathways control Wnt signaling 
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(Yamamoto et al. 2008). Fz has also been shown to internalize upon Wnt activation. 
Wnt3a induces rapid Fz5 internalization into Rab5-dependent vesicles, and it is shuttled 
back to the membrane by Rab11-positive endosomes (Yamamoto et al. 2006). Similar 
to LRP6, the interaction between AP2 and Dvl is essential for clathrin-mediated Fz 
endocytosis and Wnt activation (Yu et al. 2007). In summary, there is compelling 
evidence to support a role for both clathrin and caveolin-mediated receptor endocytosis 
in Wnt signaling. It remains unclear, however, how a cell chooses to undergo Wnt 
signaling by utilizing either mechanisms, how Wnt signaling may lead to distinct outputs 
depending on whether it is via the clathrin or caveolin pathways, and how signaling via 
the clathrin or caveolin pathways are distinctly controlled.  
In the current body of work, I address two major questions in the Wnt field and 
demonstrate that they are linked: the role of APC in Wnt signaling and the role of the 
endocytic pathway in Wnt receptor activation. In the latter case, because endocytosis 
has been shown to be absolutely required for Wnt signaling and because its 
requirement is evolutionarily conserved, understanding its role in receptor activation will 
be extremely important for our understanding of the basic mechanism of Wnt pathway 
activation. Because mutations in the tumor suppressor, APC, occur in 80% of all cases 
of sporadic CRC (accounting for 600,000 deaths annually worldwide) our understanding 
of the former case has obvious important clinical implications. 
In Chapter III, I describe the initial characterization of an inhibitory monoclonal 
antibody (mAb7E5) developed against the extracellular domain of LRP6, and 
demonstrate that mAb7E5 potently inhibited Wnt signaling. In Chapter IV, using 
mAb7E5, I show that mutations in APC lead to clathrin-dependent, ligand-independent 
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activation of the Wnt pathway. Furthermore, I demonstrate that whether Wnt signaling 
occurs via the clathrin or via caveolin-mediated endocytosis is dictate by the cell type of 
the responding cell. Finally, in Chapter V, I discuss the biological significance of my 
findings and how it has revised our current model of the Wnt pathway. 
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CHAPTER II 
MATERIALS AND METHODS 
 
Cell lines 
The following cells were generous gifts: HEK293 STF (J. Nathans, Johns Hopkins 
University), RPE (I. Kaverina, Vanderbilt University), MEF and MEF PORCNKO (C. 
Murtaugh, University of Utah), 293FT (D. Carbone, Ohio State University), HEK293T 
Dvl TKO (S. Angers, University of Toronto), and HCT116 WTKO (B. Vogelstein, Johns 
Hopkins University). HEK293, RKO, SW480, DLD1, L-Wnt3a, L-cells, and MEF 
Caveolin-1KO were purchased from the American Type Culture Collection. HEK293 
CMV-luc was reported previously (Thorne et al. 2010). Cell lines were maintained in 
DMEM except for SW480 and DLD1 cells (RPMI) and HCT116 cells (McCoy’s) with 
10% FBS and 1% penicillin/streptomycin. See also table 2.1. 
 
Drosophila RNAi lines, Gal4 driver, and progenitor cell reporter 
The following Drosophila strains were used: Apc1Q8 (Ahmed et al. 1998), Apc1 RNAi 
line (Vienna Drosophila Resource Center [VDRC] #51469), four Arr RNAi lines (Arri1, 
VDRC#4819; Arri2, VDRC #6707; Arri4, VDRC #6708; and Arri3, Bloomington Drosophila 
Stock Center (BDSC) #53342), two dsh RNAi lines (dshi1, BDSC #31306; dshi2, VDRC 
#101525), UAS-dicer2, VDRC #60010, and esgts (esg-gal4 tubgal80ts UAS-GFP/CyO) 
(Micchelli and Perrimon 2006; Guo et al. 2013). 
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Transfections 
Plasmid transfections were performed using CaCl2, Lipofectamine 3000 (Invitrogen), or 
FuGene HD (PROMEGA). siRNA transfections were performed using Dharmafect1 
(HEK293 and RKO cells), Dharmafect2 (SW480, DLD1, and HCT116 cells) (both from 
Dharmacon), or HiPerfect (RPE cells) (Qiagen) according to manufacturer’s protocol. 
siRNAs were transfected in a pool consisting of two distinct siRNAs in all experiments 
except where noted. 
 
Immunoblots and immunoprecipitation 
Whole cell lysates were obtained using non-denaturing lysis buffer (NDLB) (50 mM Tris-
Cl (pH 7.4), 300 mM NaCl, 5 mM EDTA, 1% (w/v) Triton X-100, 1mM PMSF, 1 mM 
sodium orthovandate, 10 mM NaF, and phosphatase inhibitor cocktail (Roche). Soluble 
fractions were prepared for immunoblotting. Cytoplasmic fractionation was performed as 
previously describe (Thorne et al. 2010). Cells were incubated on ice in lysis buffer (10 
mM HEPES (pH 7.8), 10 mM KCl, 2 mM MgCl2, 0.1 mM EDTA, 1mM PMSF, 1 mM 
sodium orthovandate, 10 mM NaF, and phosphatase inhibitor cocktail (Roche)), 
scraped, transferred to microfuge tubes, and NP-40 was added to 0.5%. Lysates were 
vortexed and sheared 8 times using a 23-gauge needle. Lysates were centrifuged at 
16,000Xg for 2 minutes. Supernatants (cytoplasmic fractions) were recovered. For co-
immunoprecipitations, cell lysates were prepared using NDLB. Lysates were diluted to 1 
mg/ml and incubated with antibody for 1 hour in a TOMY shaker at 4°C followed by 
addition of Protein G magnetic beads (New England Biolabs) for 1 hour. Beads were 
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then washed 3 times with 10X volume of NDLB. Proteins were eluted from beads with 
protein sample buffer and analyzed by SDS-PAGE and immunoblotting. 
Chemiluminescence signal was detected using a C-DiGit blot scanner (LI-COR). 
Obtained images and band intensity were analyzed using Image Studio (LI-COR). 
 
Generation of the mAb7E5 antibody 
A protein fragment corresponding to the fragments LRP6-1, LRP6-2, and LRP6-3 of the 
extracellular domain of human LRP6 was used to inoculate mice for monoclonal 
antibody production. Positive clones were initially identified based on their capacity to 
inhibit Wnt3a-mediated signaling in HEK293 STF cells. Clones were then screened for 
their capacity to inhibit Wnt signaling in the SW480 CRC cell line.  
 
Generation of RKO APCKO 
Two APC gRNA sequences (5’-CCCCCTATGTACGCCTCCC-3’ and 5’-
CTTTGACAAACTTGACTTT-3’) were cloned into pCAS-Guide-eGFP (Origene) using 
the restriction enzymes BamHI and BsmBI. APC gRNA oligos were designed with a 5’-
GATCG overhang and an extra guanidine nucleotide on the 3’-end of the sequence 
(Sigma). Oligonucleotides were annealed as per manufacturer’s protocol using a 4-step 
PCR procedure. Digested pCAS-Guide-eGFP vector was ligated to the annealed oligos 
using T4 ligase. Successful clones were sequence-verified. Plasmids encoding the two 
APC gRNA sequences were transfected into RKO cells at 80% confluence using 
Fugene HD. Transfected cells were sorted by flow cytometry (Vanderbilt Flow 
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Cytometry Core) as single cells into a 96-well plate. Single colonies were grown to 
confluence and split into 24-well plates. Clones were propagated and screened by 
TOPflash. Clones that showed activation as compared to a vector control were further 
screened by immunofluorescence and stained for β-catenin. Clones with high levels of 
β-catenin were further screened by immunoblotting.  
 
Generation of stable cell lines 
RKO, DLD1, HCT116 WTKO, and RPE cells were incubated with 1.5 mL of TOPflash or 
APC shRNA lentivirus, and RKO APCKO cells were incubated with 1.5 mL TIR1-9myc 
retrovirus with 12 g of polybrene (hexadimethrine bromide) for 4 hours. Media was 
removed and cells were incubated for 48 hours prior to selection with puromycin or 
G418. 
 
Sucrose density gradients 
Lysates from RKO, RKO incubated for 2 hours with 20ng recombinant Wnt3a (Times 
Bioscience), and RKO APCKO were prepared using NDLB as previously described. 
Lysates were added on top of sucrose gradients containing equal volumes of 5%, 10%, 
20%, and 30% sucrose in PBS (137 mM NaCl, 7 mM Na2HPO4, and 3 mM NaH2PO4, 
pH 7.2). Gradients were centrifuged for 4 hours at 46,000 rpm in a SW55Ti swinging-
bucket rotor (Beckman Coulter) along with molecular weight standards (Bio-Rad). After 
centrifugation, fractions were collected and precipitated using a protein precipitation kit 
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(National Diagnostics) according to manufacturer’s protocol. Precipitated proteins were 
resuspended in sample buffer and analyzed by immunoblotting. 
 
Endocytosis assays 
Cells were plated in four 35 mm dish and incubated at 37°C with L-cells conditioned 
media (L CM), Wnt3a Conditioned Media (Wnt3a CM) or 20 ng/ml recombinant Wnt3a 
(Time Bioscience) for 24 hours. Cells were then incubated at 4°C for 3 hours. Cells 
were lysed in NDLB at 0, 1, 2, and 3 hours post temperature shift. For recovery assays, 
dishes were then shifted back to 37°C, and lysates were taken 0, 1, 2, and 3 hours later. 
For small molecule experiments, cells were pre-incubated for 30 minutes with specified 
concentrations of chloroquine, pitstop-2, and nystatin. Cells were then incubated with 20 
ng/ml recombinant Wnt3a (Time Bioscience) for 2 hours. Cells were then washed with 
ice cold PBS and lysed with NDLB or analyzed by confocal microscopy. 
 
Microscopy 
For -catenin staining, cells were fixed in methanol at -20°C followed by washing with 
TBS plus 0.1% Triton X-100. Cells were then blocked in Abdil buffer (TBS, 0.1% Triton 
X-100, 2% BSA, and 0.1% sodium azide) overnight at 4°C. Cells were washed with TBS 
plus 0.1% Triton X-100 and incubated with anti--catenin antibody (1:250, Vanderbilt 
Protein and Antibody Resource). Cells were incubated with anti-mouse secondary 
antibody conjugated to Alexa Fluor 488 in a 1:1000 dilution. Cells were mounted in 
ProLong Gold Antifade Reagent with DAPI (Invitrogen). Images were acquired using a 
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CoolSNAP ES camera mounted on a Nikon Eclipse 80i fluorescence microscope using 
40X and 60X objectives. For immunostaining with APC and clathrin antibodies, RPE 
cells were seeded on 12 mm glass coverslips and cultured for 24 hours. Cells were then 
either untreated or treated with Wnt Ligand (20 ng/ml) and incubated in tissue culture for 
additional 2 hours. Cells were fixed at 37°C for 20 minutes in 4% paraformaldehyde in 
PBS. The reaction was quenched by rinsing cells 3X with 100 mM glycine in PBS 
followed by blocking and permeabilization for 1 hour with 0.1% TX-100 in PBS 
containing 5% glycine and 5% goat serum for 1 hour at room temperature. Cells were 
then incubated with mouse anti-APC antibody (Santa Cruz) and rabbit anti-clathrin 
heavy chain monoclonal antibody (1:200, Cell Signaling) or rabbit anti-caveolin-1 
polyclonal antibody (1:200, BD Transduction Laboratories) in blocking buffer with 0.05% 
Tx-100 for 2 hours at room temperature. Cells were rinsed with PBS and incubated for 1 
hour in a 1:300 dilution of Alexa Fluor 488- and Alexa Fluor 546-conjugated secondary 
antibodies. After washing in PBS, the coverslips were mounted on glass slides using 
Prolong Gold Antifade Reagent. Fluorescent images were acquired using a Zeiss LSM 
510 confocal microscope (Carl Zeiss Microscopy, Inc.; Thornwood, NY) using a Plan-
Apochromat 100X/1.4 oil Neofluar oil immersion objective with Argon/2 30mW laser 
(458, 488, 514 nm) or HeNe lasers (543 or 633 nm). 
 
Live cell imaging 
Cells were plated in 35 mm glass bottom dishes (MatTek Corporation) at ~50% 
confluency and transfected with LRP6-eYFP for 6h. Media was then removed and 
replaced with red phenol-free DMEM + 10% FBS. Cells were pre-incubated for 30 
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minutes with small molecules or mAb7E5 and/or incubated with 20ng recombinant 
Wnt3a for 2 hours. Images were obtained using a Leica TCS SP5 confocal microscope 
with 63X objective. For time-lapse live cell imaging one control stack was taken of 7-10 
cells using “mark and find” (Leica Application Suite). Wnt3a was added to the MatTek 
dish, refocusing was done, and subsequent z-stacks of the same cells were taken every 
9 minutes for 3 hours. Imaging, was done on a Leica SP5 confocal microscope using 
the Live Cell Controller by Live Cell at 37°C and 85-90% relative humidity. The 561nm 
laser was used for excitation, and the laser power remained the same during acquisition 
for each experiment. This eliminated cells not visible under a certain threshold of 
brightness to account for heterogeneity in plasmid expression of transiently transfected 
plasmids.  
 
Line scans analysis 
Images or maximum-intensity projections of z-stacks were analyzed using ImageJ 
(National Institutes of Health, Bethesda, MD). Line scans analyses to quantify nuclear -
catenin or LRP6-eYFP signal intensity were performed using ImageJ. At least five 
representative cells were measured per condition.  
 
Drosophila RNAi experiments 
To induce temporal knockdown in progenitor cells, RNAi-mediated knockdown was 
performed using the temperature-sensitive progenitor cell driver esgts. For knockdown, 
crosses with Arr RNAi lines were maintained at 18°C until late third instar, when larvae 
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were shifted to the restrictive temperature of 29°C to allow RNAi-mediated knockdown 
during pupation. Crosses with the dsh RNAi lines, were maintained at 18°C and shifted 
to 29°C during the second instar larval stage. 
Genotype for Arrow knockdown in Apc1 null mutant: esg-Gal4 tubGal80ts UAS-GFP/ 
UAS-Arrow RNAi; Apc1Q8 
Genotype for simultaneous knockdown of Arrow and Apc1: UAS-dicer2/+; esg-Gal4 
tubGal80ts UAS-GFP/+ or UAS-Arrow RNAi; UAS-Apc1 RNAi/UAS-Arrow RNAi or +. 
 Genotype for simultaneous knockdown of Dsh and Apc1: UAS-dicer2/+; esg-Gal4 
tubGal80ts UAS-GFP/+ or UAS-dsh1 RNAi; UAS-Apc1 RNAi/UAS-dsh1 RNAi or +. 
 
Drosophila Immunohistochemistry 
Two-day-old adult intestines were dissected in PBS and fixed in 4% paraformaldehyde 
in PBS for 45 minutes. Tissues were washed with PBS, 0.1% Triton X-100, followed by 
incubation in PBS, 0.1% Tween-20 and 10% BSA for 1 hour at room temperature. The 
samples were incubated with chicken anti-GFP antibody (1:10000, Abcam) at 4°C 
overnight in PBS, 0.5% Triton X-100. Samples were stained with secondary antibody 
goat anti-chicken Alexa Fluor 488 in a 1:400 dilution for 2 hours at room temperature, 
stained with DAPI (2 μg/ml), and mounted in Prolong Gold (Invitrogen). Confocal 
images were obtained from the R4 region of the posterior midgut with a Nikon A1RSi 
confocal microscope with 60x lens, and the total number of esg-positive cells in a field 
of 0.051 mm2 was counted. For all quantification, more than 15 posterior midguts of 
55 
 
each genotype were analyzed. Images were processed using Adobe Photoshop 
software.  
 
Auxin-dependent degradation assay 
RKO APCKO TIR1 cells were plated in 35 mm dishes, and transfected with pCS2 Myc-
APCT or pCS2 AID-Myc-mCherry-APCT. At 24 hours post-transfection, cells were 
incubated with 500 M auxin analog 1-Naphthaleneacetic acid (Sigma). Timepoints 
were taken every 30 minutes for 2 hours, and cells were lysed in NDLB and 
immunoblotted. 
 
Reporter assay 
For cell-based luciferase assays, HEK293 STF, RKO STF, SW480 STF, DLD1 STF, 
HCT116 STF, HCT116 WTKO STF, and HEK293 CMV-Luc cells were seeded into 24-
well plates at ~50% confluency. Cells were incubated with L CM, Wnt3a CM, 20 ng/ml 
purified Wnt3a (Time Bioscience), or 30 mM LiCl prior to lysis with 1X Passive Lysis 
buffer. Luciferase expression was measured using Steady-Glo Luciferase Assay 
(Promega). For inhibitor studies, cells were incubated with mAb7E5, Wnt-C59 (Cellagen 
Technology), IWP-2 (StemRD) or Fz8-Fc (R&D Systems) for 24 hours (with the 
exception of 48 hours for SW480, DLD1, and HCT116 cells) prior to lysis. Luciferase 
signal was normalized to viable cell number using CellTiter-Glo Assay (Promega). 
Alternatively, TOPflash experiments in HEK293, HEK293 Dvl TKO, MEF, MEF 
PORCNKO, MEF Caveolin-1KO, RKO, and RKO APCKO cells were performed as follows. 
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Cells were plated and co-transfected with TOPflash and Renilla expression plasmids 24 
hours later. Cells were lysed using Dual-Glo Assay (Promega), and luciferase signal 
was normalized to co-transfected Renilla expression. For each experiment, data was 
normalized to the signal obtained from positive controls (plotted as 100% activation). 
Assays were performed in quadruplicate and repeated at least 3X.  
 
RNA isolation and qRT-PCR 
HEK293 cells were treated with LRP6 siRNA and APC siRNA for 72 hours. Cells were 
then harvested using STAT60 reagent (Amsbio) according to manufacturer’s protocol 
and further purified using RNeasy purification kit (Qiagen). RNA (2 g) was reverse 
transcribed to cDNA using High-Capacity cDNA Reverse Transcription Kit (Thermo 
Scientific). qRT-PCR was performed on a Bio-Rad C1000 thermocycler using 
predesigned and revalidated TaqMan probes that span exons (Thermo Scientific). 
GAPDH was used as reference control. Technical duplicates were performed for each 
gene. 
 
Statistical analysis 
All graphs were made using Prism (GraphPad Software, Inc.). Statistical analyses were 
performed using a two-tailed, unpaired Student's t-test, except for colocalization 
analyses. A value of p<0.05 is considered statistically significant.  
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Colocalization Analysis 
For colocalization analysis, Intensity Correlation Analysis plugin in Fiji was used. 
Pearson’s Correlation coefficients were calculated using 4X zoom images. 10-19 
images were analyzed for each condition. Box and Whisker plot was plotted for 
reporting Pearson’s Correlation Coefficients. A two-tailed, unpaired, non-parametric 
Mann-Whitney U-test was used for calculating p-values. 
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CHAPTER III 
INHIBITION OF THE WNT PATHWAY BY A MONOCLONAL ANTIBODY AGAINST 
THE CO-RECEPTOR LRP6 
 
Introduction 
Given the fact that there are nineteen Wnt ligands, ten Frizzled receptors, and 
only two LRPs, it would be logical to target LRP5 or 6 as the most efficient way to 
globally inhibit Wnt signaling.  LRP5 and LRP6 are 70% identical, however LRP6 has 
been proposed to play a more significant role in Wnt signaling transduction (He et al. 
2004). Indeed, LRP6 overexpression but not LRP5 results in Wnt pathway activation in 
vivo and in mammalian cells (Mi and Johnson 2005; MacDonald et al. 2011). The 
extracellular domain (ECD) of LRP6 contains four YWTD -propellers followed by four 
Epidermal Growth Factor-like domains (E1 through E4). These domains bind different 
Wnt ligands. For instance, Wnt1 binds E1 and E2, whereas Wnt3a bind E3 and E4. Wnt 
antagonists such as DKK1 compete for the same domains that Wnt ligands bind to, 
thereby supporting a model for Wnt inhibition by DKK1 through ligand competition 
(Chen et al. 2011; Cheng et al. 2011). Wnt-binding to LRP6 induces a conformational 
change in the ECD due to a hinge-like structure found between E2 and E3 (Cheng et al. 
2011). This conformational change is thought to act as a regulatory step that prevents 
constitutive Wnt activation. Agreeing with this model, expression of a truncated LRP6 
missing the extracellular domain leads to higher levels of Wnt activation compared to 
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that of full-length LRP6, suggesting that the extracellular domain of LRP6 auto-inhibits 
its activation (Liu et al. 2003). 
Multiple antibodies targeting the LRP6 ECD that can inhibit or potentiate ligand-
dependent Wnt activation have been reported (Ettenberg et al. 2010; Gong et al. 2010). 
Because Wnt ligands bind to the two distinct domains of LRP6 ECD (E1E2 and E3E4), 
treatment with at least two distinct antibodies may be necessary to prevent all Wnt 
activation. Using a bioinformatics approach, we identified three regions from the LRP6 
ECD that are highly conserved across phyla. We developed an antibody (mAb7E5) 
against those three regions, and we show that mAb7E5 inhibits ligand-dependent Wnt 
activation of the Wnt1 and Wnt3a class. Furthermore, we found that mAb7E5 inhibits 
Wnt activation in the triple-negative breast cancer cell line MDA-MB-231, which 
expresses high levels of LRP6, suggesting that mAb7E5 can potentially be developed 
as a therapeutic agent for the treatment of Wnt-driven cancers. 
 
Results 
Development of an antibody that inhibits LRP6 
To identify LRP6 antibodies that regulate Wnt signaling we performed alignments 
of DNA sequences of LRP6 across multiple species to find highly similar regions. We 
identified three highly conserved regions (LRP6-1, LRP6-2, and LRP6-3) located 
between E2 and E3 (Figure 3.1A and B). These regions were of particular interest 
because the LRP6 hinge, which facilitates LRP6 activation, connects E2 and E3 (Chen 
et al. 2011). Monoclonal antibodies against a fusion of LRP6-1, LRP6-2, and LRP6-3 
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(LRP6-1,2,3) fragments were generated and tested for their capacity to suppress Wnt 
signaling in HEK293 cells stably expressing the Wnt reporter TOPflash (HEK293 STF) 
(Thorne et al. 2010) (Thorne et al. 2010). We identified the clone 7E5 (herein referred 
as mAb7E5) as the most potent Wnt inhibitor as measured by TOPflash (Figure 3.2A). 
Interestingly, mAb7E5 was expressed as an IgM. To confirm that the observed inhibition 
was not due to the multivalent nature of IgMs, we cloned the variable region of mAb7E5 
into an IgG backbone. We found that both mAb7E5 IgM and IgG inhibited Wnt activation 
in HEK293 cells (Figure 3.2B). Furthermore, we tested whether the Fab fragment of 
mAb7E5 (mAb7E5Fab) could also inhibit Wnt signaling. Similar to mAb7E5 IgM, and 
mAb7E5 IgG, mAb7E5Fab inhibited Wnt3a-mediated TOPflash activity and -catenin 
accumulation (Figure 3.2C). These results confirm that mAb7E5 effectively inhibits Wnt 
signaling.  
 
mAb7E5 inhibits ligand-mediated Wnt activation 
Activation of the Wnt pathway involves multiple coordinated events that occur 
downstream of the Wnt receptors. Key steps are activation of LRP6 (measured by an 
increase in LRP6 phosphorylation at Thr1572) and accumulation of cytoplasmic -
catenin (Saito-Diaz et al. 2012). Because mAb7E5 is a potent inhibitor of the Wnt 
pathway, we further characterized its effects on the various steps required for Wnt 
activation. Agreeing with our initial screening results, mAb7E5 blocked Wnt3a-
dependent TOPflash activity in the human cell lines HEK293 STF and RKO STF, which 
correlated with decreased cytoplasmic -catenin levels and decreased Wnt-mediated 
61 
 
LRP6 phosphorylation (Figure 3.3A and B). These results were confirmed by 
immunofluorescence in the Retinal Pigment Epithelium (RPE) cell line. mAb7E5 
decreased the number of RPE cells with elevated levels of nuclear -catenin staining, 
compared to RPE cells treated with Wnt3a alone (Figure 3.3C). Furthermore, mAb7E5 
inhibited Wnt activation by Wnt3a and Wnt1, which bind different domains of LRP6 
(Figure 3.1B and Figure 3.3D). Taken together, these results confirm that mAb7E5 
inhibits Wnt signaling at the level of the co-receptor, LRP6.  
 
mAb7E5 binds specifically to LRP6 
To confirm that mAb7E5 interacts with the LRP6 ECD and to identify its binding 
region on the LRP6 ECD, we added a Histidine (His) tag to the C-terminal domain of the 
IgG heavy chain. We performed pull-down studies with the His-tagged mAb7E5 and 
purified maltose binding protein (MBP)-tagged LRP6-1, LRP6-2, and LRP6-3 fragments. 
We found that mAb7E5 binds to LRP6-2 and LRP6-3, as well as the fusion LRP6-1,2,3 
(Figure 3.4A and B). 
To confirm that mAb7E5 inhibited Wnt signaling via direct interaction with LRP6, 
cells were transfected with full-length LRP6 (LRP6 FL) or a constitutively active 
truncated-LRP6 missing the extracellular domain (LRP6N) (Liu et al. 2003). As 
predicted, mAb7E5 inhibited Wnt activation by LRP6 FL overexpression but not by 
LRP6N overexpression (Figure 3.5A). To rule out effects by mAb7E5 downstream of 
LRP6, we inhibited GSK3 using lithium chloride in HEK293 STF. As predicted, mAb7E5  
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LRP6-1            1 -----------------LLGDYVYWTDWQRRSIERVHKRSAE-REVIIDQLPDLMGLKAT 
H.sapiens       523 GRRVLVEDKIPHIFGFTLLGDYVYWTDWQRRSIERVHKRSAE-REVIIDQLPDLMGLKAT 
M.musculus      523 GRRVLVEDKIPHIFGFTLLGDYVYWTDWQRRSIERVHKRSAE-REVIIDQLPDLMGLKAT 
R.norvegicus    372 GRRVLVEDKIPHIFGFTLLGDYVYWTDWQRRSIERVHKRSAE-REVIIDQLPDLMGLKAT 
X.laevis        523 GRRVLVEDKLPHIFGFTLLGDYVYWTDWQRRSIERVHKRTGE-REVIIDQLPDLMGLKAT 
D.melanogaster  598 GRRVVISDNLKHLFGLSILDDYLYWTDWQRRSIDRAHKITGNNRIVVVDQYPDLMGLKVT 
 
 
LRP6-1           43 NVHRVIGSNPCAEENGGCSHLCLYRPQGLRCACPIGFELISDMKTCIVPEAFLLFSRRAD 
H.sapiens       582 NVHRVIGSNPCAEENGGCSHLCLYRPQGLRCACPIGFELISDMKTCIVPEAFLLFSRRAD 
M.musculus      582 SVHRIIGSNPCAEDNGGCSHLCLYRPQGLRCACPIGFELISDMKTCIVPEAFLLFSRRAD 
R.norvegicus    431 SVHRVIGSNPCAEENGGCSHLCLYRPQGLRCACPIGFELISDMKTCIVPEAFLLFSRRAD 
X.laevis        582 NIHKLSGTNGCAENNGGCSHLCLYRPQGPRCACPIGLELINDMKTCIVPEAFLLFSRRAD 
D.melanogaster  658 RLREVRGQNACAVRNGGCSHLCLNRPRDYVCRCAIDYELANDKRTCVVPAAFLLFSRQEH 
 
 
LRP6-1          103 IRRISLETN---NNNVAIPLTGVKEASALDFDVTD------------------------- 
H.sapiens       642 IRRISLETN---NNNVAIPLTGVKEASALDFDVTDNRIYWTDISLKTISRAFMNGSALEH 
M.musculus      642 IRRISLETN---NNNVAIPLTGVKEASALDFDVTDNRIYWTDISLKTISRAFMNGSALEH 
R.norvegicus    491 IRRISLETN---NNNVAIPLTGVKEASALDFDVTDNRIYWTDISLKTISRAFMNGSALEH 
X.laevis        642 IRRISLETS---NTHVAIPLTGVKEASALDFDVTDNRIYWTDVSLKTISRAFMNGSALRH 
D.melanogaster  718 IGRISIEYNEGNHNDERIPFKDVRDAHALDVSVAERRIYWTDQKSKCIFRAFLNGSYVQR 
 
 
LRP6-2          135 --EFGLDYPEGMAVDWLGKNLYWADTGTNRIEVSKLDGQHRQVLVWKDLDSPRALALDPA 
H.sapiens       699 VVEFGLDYPEGMAVDWLGKNLYWADTGTNRIEVSKLDGQHRQVLVWKDLDSPRALALDPA 
M.musculus      699 VVEFGLDYPEGMAVDWLGKNLYWADTGTNRIEVSKLDGQHRQVLVWKDLDSPRALALDPA 
R.norvegicus    548 VVEFGLDYPEGMAVDWLGKNLYWADTGTNRIEVSKLDGQHRQVLVWKDLDSPRALALDPA 
X.laevis        699 VVQFGLDYPEGMAVDWLGKNLYWADTGTNRIEVSKLDGQHRQILVWKDLDSPRALALDPA 
D.melanogaster  778 IVDSGLIGPDGIAVDWLANNIYWSDAEARRIEVARLDGSSRRVLLWKGVEEPRSLVLEPR 
 
 
LRP6-2          193 EGFMYWTEWGGKPKIDRAAMDGSERTTLVPNVGRANGLTIDYAKRRLYWTD-LDTNLIES 
H.sapiens       759 EGFMYWTEWGGKPKIDRAAMDGSERTTLVPNVGRANGLTIDYAKRRLYWTD-LDTNLIES 
M.musculus      759 EGFMYWTEWGGKPKIDRAAMDGSERTTLVPNVGRANGLTIDYAKRRLYWTD-LDTNLIES 
R.norvegicus    608 EGFMYWTEWGGKPKIDRAAMDGSERTTLVPNVGRANGLTIDYAKRRLYWTD-LDTNLIES 
X.laevis        759 EGFMYWTEWGGKPKIDRTAMDGSGRITLVPDVGRANGLTIDYAERRLYWTD-LDTNLIES 
D.melanogaster  838 RGYMYWTESP-TDSIRRAAMDGSDLQTIVAGANHAAGLTFDQETRRLYWATQSRPAKIES 
 
 
LRP6-2          252 SNMLGLNREV-IADDLPHPFGLTQYQDYIYWTDWS------------------------- 
H.sapiens       818 SNMLGLNREV-IADDLPHPFGLTQYQDYIYWTDWSRRSIERANKTSGQNRTIIQGHLDYV 
M.musculus      818 SDMLGLNREV-IADDLPHPFGLTQYQDYIYWTDWSRRSIERANKTSGQNRTIIQGHLDYV 
R.norvegicus    667 SNMLGLNREV-IADDLPHPFGLTQYQDYIYWTDWSRRSIERANKTSGQNRTIIQGHLDYV 
X.laevis        818 SNMLGLDRVV-IADDLPHPFGLTQYQDYIYWTDWSRRSIERANKTSGQNRIMIQNDLDYV 
D.melanogaster  897 ADWDGKKRQILVGSDMDEPYAVSLYQDYVYWSDWNTGDIERVHKTTGQNRSLVHSGMTYI 
 
 
LRP6-3          286 -------------------------------------------------DNRTCSAPTTF 
H.sapiens       877 MDILVFHSSRQSGWNECASSNGHCSHLCLAVPV-GGFVCGCPAHYSLNADNRTCSAPTTF 
M.musculus      877 MDILVFHSSRQAGWNECASSNGHCSHLCLAVPV-GGFVCGCPAHYSLNADNRTCSAPTTF 
R.norvegicus    726 MDILVFHSSRQAGWNECASSNGHCSHLCLAVPV-GGFVCGCPAHYSLNADNRTCSAPTTF 
X.laevis        877 MDILVFHSSRQAGWNECASSNGHCSHLCLATPI-SGYTCGCPVHHSLNTDNKTCSAPSSF 
D.melanogaster  957 TSLLVFNDKRQTGVNPCKVNNGGCSHLCLAQPGRRGMTCACPTHYQLAKDGVSCIPPRNY 
 
 
LRP6-3          297 LLFSQKSAINRMVIDEQQSPDIILPIHSLRNVRAIDYDPLDKQLYWIDSRQNMIRKAQED 
H.sapiens       936 LLFSQKSAINRMVIDEQQSPDIILPIHSLRNVRAIDYDPLDKQLYWIDSRQNMIRKAQED 
M.musculus      936 LLFSQKSAINRMVIDEQQSPDIILPIHSLRNVRAIDYDPLDKQLYWIDSRQNSIRKAHED 
R.norvegicus    785 LLFSQKSAINRMVIDEQQSPDIILPIHSLRNVRAIDYDPLDKQLYWIDSRQNMIRKAQED 
X.laevis        936 LLFSQKNAINRMVIDGQQSPDIILPIHNLRNVRAIDYDPLEKQLYWIDSRQN-IRRAQED 
D.melanogaster 1017 IIFSQRNCFGRLLPNTTDCPNIPLPV-SGKNIRAVDYDPITHHIYWIEGRSHSIKRSLAN 
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LRP6-3          357 GSQGFTVVVSSVPSQNLEIQPYDLSIDIYSRYIYWTCEATNVINVTRLDGRSVGVVLKGE 
H.sapiens       996 GSQGFTVVVSSVPSQNLEIQPYDLSIDIYSRYIYWTCEATNVINVTRLDGRSVGVVLKGE 
M.musculus      996 GGQGFNVVANSVANQNLEIQPYDLSIDIYSRYIYWTCEATNVIDVTRLDGRSVGVVLKGE 
R.norvegicus    845 GGQGFTVVVSSVPNQNLEIQPYDLSIDIYSRYIYWTCEATNVIDVTRLDGRSVGVVLKGE 
X.laevis        995 GSQSMTIVASTIPNQNMDMQPYDLSIDIYSRLIYWTCEATNIINVTRLDGRAIGVVLKGE 
D.melanogaster 1076 GTKVS-LLAN-------SGQPFDLAIDIIGRLLFWTCSQSNSINVTSFLGESVGVIDTGD 
 
 
LRP6-3          417 QDRPRAIVVNPE------------------------------------------------ 
H.sapiens      1056 QDRPRAIVVNPEKGYMYFTNLQERSPKIERAALDGTEREVLFFSGLSKPIALALDSRLGK 
M.musculus     1056 QDRPRAIVVNPEKGYMYFTNLQERSPKIERAALDGTEREVLFFSGLSKPIALALDSKLGK 
R.norvegicus    905 QDRPRAIVVNPEKGYMYFTNLQERSPKIERAALDGTEREVLFFSGLSKPVALALDSKLSR 
X.laevis       1055 QERPRAILVNPERGYMYFTNLQERSPKIERAALDGSEREVLFFTGLSKPVALALDNKMGK 
D.melanogaster 1128 SEKPRNIAVHAMKRLLFWTDVGSHQ-AIIRARVDGNERVELAY-KLEGVTALALDQQSDM 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1. LRP6 domains selected as antigen for antibody development. 
(A) DNA sequences of LRP6-1, LRP6-2, and LRP6-3 aligned with LRP6 sequence of 
multiple species. 
(B) Approximate location of LRP6-1, LRP6-2, and LRP6-3 within full-length LRP6. -P, 
-propeller; EGF, epidermal growth factor-like domain. Wnt1 and Wnt3a binding sites 
are shown. 
 
 
 
B 
-P1 EG
F
1
 
-P2 EG
F
2
 
Hinge 
LRP6-1 
Wnt1 
EG
F1
 
EG
F2
 
64 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2. The monoclonal antibody mAb7E5 is an inhibitor of the Wnt pathway. 
(A) Screening of multiple clones of monoclonal antibodies. HEK293 STF cells were 
incubated with Wnt3a and monoclonal antibodies. 
(B) The monoclonal antibody mAb7E5 inhibits Wnt activation regardless of its isotype. 
HEK293 STF cells were incubated with L (L CM) or Wnt3a (Wnt3a CM) conditioned 
media and mAb7E5 IgG or mAb7E5 IgM. 
(C) mAb7E5Fab can inhibit ligand-dependent Wnt signaling. HEK293 STF cells were 
incubated with full-length or Fab mAb7E5 and Wnt3a CM. 
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Figure 3.3. mAb7E5 inhibits ligand mediated Wnt activation. 
(A and B) mAb7E5 blocks Wnt ligand-mediated signaling (A) HEK293 STF and (B) RKO 
STF cells were incubated with Wnt3a and mAb7E5.  
(C) mAb7E5 prevents nuclear accumulation of -catenin. RPE cells were incubated with 
Wnt3a and mAb7E5 followed by fixation and immunostaining. Scale bar: 5 m. Inset: 
Line scans of selected cells. Scale bar: 10 m. Cells (>100/condition) showing nuclear 
-catenin staining were quantified and plotted. 
(D) mAb7E5, inhibits Wnt signaling mediated by the Wnt3a and Wnt1 classes of ligands 
and by elevated LRP6. HEK293 STF were transfected with plasmids encoding Wnt3a, 
Wnt1, LRP6 or vector control in the presence or absence of mAb7E5.   
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Figure 3.4. mAb7E5 binds to LRP6-2 and LRP6-3 domains in vitro.  
(A) MBP-tagged LRP6-1, LRP6-2, and LRP6-3 fragments were purified and incubated 
with His-mAb7E5. Samples were analyzed by SDS-PAGE electrophoresis and 
interaction between mAb7E5 and each LRP6 fragment was assessed by 
immunoblotting. 
(B) Coomassie staining of (A) to confirm equivalent amounts of protein were used. 
Asterisk shows non-specific band. 
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Figure 3.5. mAb7E5 inhibits Wnt activation at the level of the co-receptor LRP6 
(A) The extracellular domain of LRP6 is required for mAb7E5 to inhibit LRP6-mediated 
Wnt signaling. HEK293 STF cells were transfected with LRP6N or LRP6 FL and 
incubated with mAb7E5.  
(B) mAb7E5 blocks Wnt signaling upstream of the degradation complex. HEK293 STF 
cells were incubated with mAb7E5 and 30 mM LiCl.  
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did not block Wnt reporter activity or accumulation of cytoplasmic -catenin upon lithium 
treatment (Figure 3.5B). These results provide strong evidence that mAb7E5 inhibits 
Wnt signaling at the level of LRP6. 
 
mAb7E5 inhibits Wnt signaling in breast cancer cells 
Three major markers are currently used for guiding clinical diagnosis and 
treatment of breast cancer: estrogen receptor expression, epidermal growth factor 
receptor expression, and aberrant HER2 expression. Triple-negative breast cancer 
(TNBC) is defined as the subtype of breast cancer lacking expression of all three 
markers, and is considered highly aggressive and patients exhibit poor prognosis 
(Banerjee et al. 2006; Bianchini et al. 2016).  
MDA-MB-231 is a TNBC cell line, which exhibits constitutive Wnt signaling due to 
an autocrine signaling loop. Incubation with the Wnt inhibitors DKK1 and SFRP1 
prevent -catenin accumulation and Wnt activation in this cell line (Bafico et al. 2004). 
MDA-MB-231 cells exhibit high levels of LRP6, and depletion of LRP6 by siRNA 
decreases Wnt signaling, viability, and proliferation of MDA-MB-231 in vitro and in 
mouse xenograft models (Bafico et al. 2004; Liu et al. 2010). Loss of Fz7 in MDA-MB-
231 cells also inhibits tumor growth in vivo (Yang et al. 2011). Because mAb7E5 targets 
LRP6, we decided to test whether mAb7E5 inhibits Wnt signaling in MDA-MB-231 cells. 
We found that both mAb7E5 and mAb7E5Fab decrease nuclear -catenin accumulation 
in MDA-MB-231 cells (Figure 3.6). In titration studies, we found that mAb7E5 is effective  
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Figure 3.6. mAb7E5 downregulates -catenin levels in MDA-MB-231 cells. 
MDA-MB-231 cells were incubated with full length mAb7E5 or mAb7E5Fab, followed by 
immunostaing. 
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Figure 3.7. Minimum mAb7E5 concentration required to inhibit -catenin 
accumulation in MDA-MB-231 cells. 
MDA-MB-231 cells were incubated with indicated concentrations of mAb7E5 followed 
by immunostaining. 
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at a concentration of 30g/ml (Figure 3.7). These results suggest that mAb7E5 can 
potentially be used as a therapeutic agent in treating TNBC. 
 
Discussion 
LRP6 is a very attractive target for developing inhibitors of the Wnt pathway for 
several reasons: (1) LRP6 is located at the plasma membrane and binds to Wnt ligands, 
(2) there are only two members of the LRP receptor family (LRP5 and LRP6), and (3) 
LRP6 is only involved in the canonical Wnt pathway. Thus, any perturbation in LRP6 
function would not have significant effects in other non-canonical functions of the Wnt 
pathway, thereby limiting toxicity (Saito-Diaz et al. 2012).  
Previously reported antibodies have been generated against the extracellular 
domain of LRP6 using antibody libraries (Ettenberg et al. 2010) or by producing them 
against purified E1-E2 and E3-E4 fragments of the LRP6 ECD (Gong et al. 2010). As a 
result, these studies identified multiple antibodies that uncovered new properties of 
LRP6. In contrast, our approach focused on bioinformatically identifying highly 
conserved regions of LRP6 ECD important for LRP6 function and Wnt signal 
transduction. Furthermore, in contrast to the reported anti-LRP6 antibodies, we found 
that mAb7E5 inhibits both Wnt1 and Wnt3a class of ligand.   
Interestingly, we found that mAb7E5 also inhibits ligand-independent Wnt 
activation. Our data shows that mAb7E5 blocks Wnt activation upon LRP6 
overexpression in human cells. This suggests that mAb7E5 may target a region of 
LRP6 that is undergoes conformational change in response to Wnt ligand binding. It has 
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been reported that ECD of LRP6 prevents constitutive LRP6 activation and, upon Wnt 
ligand binding, LRP6 undergoes a conformational change that relays the signal to 
downstream effectors. It is possible that binding of mAb7E5 blocks this conformational 
change to block LRP6 activation. Thus, the regions of LRP6-2 and LRP6-3 (targeted by 
mAb7E5) may mediate structural changes in the coreceptor that are induced by Wnt 
ligand binding.  
 The Wnt pathway is constitutively active in many diseases, including colorectal 
and breast cancer. Thus, Wnt inhibitors would be potentially beneficial for the treatment 
of these diseases. Multiple studies have reported several small molecules as candidate 
therapeutics (Blagodatski et al. 2014). These small molecules, however, suffer from low 
efficacy and selectivity, thereby limiting their potential use as therapeutics. In contrast, 
monoclonal antibodies have multiple advantages as therapeutics as they are highly 
selective and have longer half-lives than small molecules.  
Antibodies against Fz have been developed as potent Wnt inhibitors. Two 
antibodies, vantictumab and OTSA101, which targets Fz7 and Fz10, respectively, are 
currently undergoing Phase II clinical trials (Blagodatski et al. 2014). Fz7 is up regulated 
in a wide range of cancers, including CRC, TNBC, and hepatocellular carcinomas, 
whereas Fz10 is highly expressed in synovial sarcomas (King et al. 2012). Although 
vantictumab was initially identified as in inhibitor of Fz7, it has been shown to interact 
with five other members of the Fz family (Gurney et al. 2012). As a result, patients 
taking vantictumab demonstrate moderate-severe side effects, including osteoporosis (a 
side of effect of significant Wnt inhibition) (Blagodatski et al. 2014).  
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Our results suggest that antibodies against LRP6 also have the potential for 
being developed further for the treatment of Wnt-driven diseases. Just as importantly, 
these antibodies can also be used as a tool to probe how LRP6 controls Wnt pathway 
activation and possibly give us insight of unappreciated regulatory mechanisms. In the 
case of the latter, the role of mAb7E5 in deciphering the mechanism of action of the 
tumor suppressor, APC, in the Wnt pathway will be described in Chapter IV  
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CHAPTER IV 
APC INHIBITS LIGAND-INDEPENDENT WNT SIGNALING BY THE CLATHRIN 
ENDOCYTIC PATHWAY 
 
Introduction 
In the absence of a Wnt ligand, levels of cytoplasmic β-catenin are maintained at low 
levels by its association with a destruction complex consisting of the scaffold protein 
Axin, the tumor suppressor adenomatous polyposis coli (APC), and the kinases casein 
kinase 1 (CK1) and glycogen synthase kinase (GSK3). Within this complex, β-
catenin is phosphorylated and targeted for degradation by the ubiquitin-proteasome 
system (Saito-Diaz et al. 2012). Wnt ligand binding promotes the formation of a trimeric 
complex of Wnt, the co-receptors Frizzled (Fz), and the low-density lipoprotein receptor 
5/6 (LRP5/6) (Tamai et al. 2000). The formation of aggregated receptors (the 
signalosome) promotes the recruitment of Axin in a process mediated by Dishevelled 
(Dvl) (Tamai et al. 2004; Bilić et al. 2007; Zeng et al. 2008). Consequently, degradation 
of β-catenin is inhibited, its cytoplasmic levels rise, and it is translocated to the nucleus. 
Within the nucleus, β-catenin associates with the TCF family of transcription factors to 
initiate a Wnt transcriptional program (Saito-Diaz et al., 2012).  
 In the classical model, the role of APC is limited to -catenin proteolysis. Herein, 
we report that APC is also essential to inhibit Wnt receptor activation in the unstimulated 
state.  We have identified a constitutive, clathrin-mediated pathway that activates Wnt 
signaling independent of Wnt ligands upon APC inactivation. These studies provide a 
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new model for the mechanism by which the Wnt pathway is aberrantly activated upon 
APC loss and offer critical insight for the development of novel therapeutics targeting 
Wnt-driven cancers. 
 
Results 
 
LRP6 is required for Wnt pathway activation in APC mutant cells but not in cells 
with mutant -catenin 
 Loss of APC has been proposed to induce the formation of a Wnt autocrine loop 
in colorectal cancer (CRC) (Bafico et al. 2004; Voloshanenko et al. 2013). We tested the 
effects of mAb7E5 on the CRC lines SW480 and DLD1, which contain mutations in 
APC, and HCT116, which expresses stabilized -catenin. mAb7E5 inhibited Wnt 
signaling only in SW480 and DLD1 cells (Figure 4.1A and B). We found that all the CRC 
cells tested exhibit elevated levels of phospho-LRP6 that were decreased by treatment 
with mAb7E5 (Figure 4.1A). To confirm these results, we knocked down APC using 
siRNA in HEK293 and RKO cells, which increased Wnt reporter activity, -catenin 
accumulation, and phospho-LRP6 levels (Figure 4.2A-C). mAb7E5 treatment blocked all 
of the effects of APC depletion (Figure 4.2B and C). As control, mAb7E5 had no effect 
on a reporter line (HEK293-CMV) under the control of a non-Wnt regulated promoter 
(Thorne et al., 2010) (Figure 4.2D). To rule out effects of residual APC activity, we used 
CRISPR-Cas9 to generate a cell line (RKO APCKO) null for APC protein (Figure 4.3E). 
RKO APCKO cells exhibited elevated levels of phospho-LRP6 and cytoplasmic -catenin 
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(Figure 4.2E), that was downregulated with mAb7E5 treatment (Figure 4.2F). These 
findings indicate that the effects of APC loss on Wnt pathway activation are mediated 
partly through LRP6. 
 To confirm that the constitutive activation of Wnt signaling resulting from APC 
loss requires LRP6, we performed siRNA knockdown of LRP6 in HEK293 cells (Figure 
4.3A). The activation of both the Wnt reporter and endogenous Wnt target genes 
resulting from APC knockdown (on our Wnt reporter line and endogenous Wnt target 
genes) was reversed by concomitant knockdown of LRP6 (Figures 4.3B-E). A similar 
result was observed with either combined siRNA knockdown of APC in RKO cells or 
siRNA knockdown of LRP6 in RKO APCKO cells (Figure 4.3F and G). Furthermore, in 
SW480 and DLD1 cells, but not in HCT116 cells, knocking down LRP6 also inhibited 
Wnt signaling (Figure 4.3H). Together, these findings provide further evidence that the 
activation of Wnt signaling resulting from APC depletion is dependent on LRP6. 
 
Requirement for surface receptor activation but not Wnt ligands for pathway 
activation in APC mutant cells 
 We hypothesized that like LRP6, other components of the signalosome are 
required for the constitutive activation of Wnt signaling upon APC loss. Thus, inhibiting 
other membrane components (e.g., Fz and Dvl) should inhibit Wnt signaling in APC 
mutant cells. To block multiple Fz and Dvl isoforms, we expressed their dominant-
negative forms, Fz1-ER and Xdd1, respectively (Wallingford et al. 2000; Kaykas et al.  
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Figure 4.1 mAb7E5 inhibits Wnt signaling in APC-mutant CRC cells. 
(A) mAb7E5 inhibits Wnt signaling in APC mutant CRC cells. CRC cells were incubated 
for 48h with mAb7E5. 
(B) mAb7E5 prevents accumulation of nuclear -catenin in APC mutant CRC cells. 
Scale bar: 40 m.  
Graph shows mean ± s.e.m. n.s., non-significant, **p<0.01, ***p<0.001. 
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Figure 4.2. mAb7E5 blocks Wnt activation in APC-deficient cells 
(A) Downregulation of APC by two distinct siRNAs. 
(B and C) mAb7E5 inhibits Wnt signaling upon APC loss. (B) HEK293 STF and (C) 
RKO STF cells were incubated with APC siRNA and mAb7E5.  
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(D) Specificity of Wnt signaling inhibition by mAb7E5 in APC-deficient cells. A non-Wnt-
regulated reporter cell line, HEK293 CMV-luc, was incubated with APC siRNA and 
mAb7E5.  
(E) Generation of RKO APCKO. Schematics of selected gRNA and characterization of 
RKO APCKO cells.  
(F) RKO APCKO cells were incubated with mAb7E5 or mAb7E5Fab followed by 
immunoblotting.  
Graph shows mean ± s.e.m. n.s., non-significant, ***p<0.001. 
  
81 
 
H 
 
 
 
 
 
 
 
 
 
 
A B C D 
E 
F G 
82 
 
 
Figure 4.3. LRP6 is required for Wnt signaling in APC-deficient cells. 
(A) Downregulation of LRP6 by two distinct siRNAs.  
(B and C) LRP6 is required for Wnt pathway activation upon loss of APC. (B) HEK293 
STF and (C) RKO STF cells transfected with cells were transfected with APC and LRP6 
siRNA. 
(D) Specificity of Wnt signaling inhibition by downregulating LRP6 in APC-deficient cells. 
The non-Wnt-regulated reporter cell line, HEK293 CMV-luc, was incubated with APC 
and LRP6 siRNAs.  
(E) Stimulation of endogenous Wnt target gene expression upon APC loss is inhibited 
by downregulating LRP6. HEK293 cells were transfected with APC and LRP6 siRNA, 
mRNAs isolated, and qRT-PCR performed.  
(F) LRP6 is required nuclear -catenin accumulation upon loss of APC. RKO cells were 
treated with APC siRNA and either LRP6 siRNA or mAb7E5 followed by 
immunostaining. Scale bar: 40 m.  
(G) RKO APCKO cells were incubated with LRP6 siRNA. Lysates were collected and 
analyzed by immunoblotting. 
(H) CRC cells were transfected with LRP6 siRNA followed by immunoblotting and 
TOPflash. 
Graph shows mean ± s.e.m. n.s., non-significant, *p<0.05, **p<0.01, ***p<0.001. 
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Figure 4.4 Loss of APC promotes ligand-independent signalosome formation.  
(A) Fz and Dvl are required for ligand-mediated Wnt activation. HEK293 STF cells were 
transfected with Xdd1 and Fz1-ER for 24 hours and then incubated with either L-cell (L 
CM) or Wnt3a (Wnt3a CM) conditioned media.  
(B) Dvl and Fz are required for Wnt activation in APC-deficient cells. HEK293 STF cells 
were transfected with APC siRNA plus Xdd1 or Fz1-ER.  
(C) APC depletion fails to activate the Wnt pathway in Dvl null cells. HEK293 and 
HEK293 Dvl TKO were transfected with APC siRNA or treated with Wnt3a CM or 30 
mM LiCl.  
(D) Wnt signaling due to -catenin stabilization is not dependent on Fz or Dvl. HEK293 
STF cells were transfected with Xdd1 or Fz1-ER and incubated with 30 mM LiCl.  
(E) Similar to Wnt ligand-activated cells, LRP6 forms high molecular complexes in the 
absence of APC on sucrose density gradient.  
Graphs show mean ± s.e.m., n.s. non-significant, **p<0.01, ***p<0.001.  
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2004) (Figure 4.4A). Fz1-ER and Xdd1 expression inhibited Wnt reporter activity and 
reduced phospho-LRP6 levels in APC-depleted cells (Figure 4.4B). Furthermore, 
knocking down APC in a cell line null for all three Dvl genes (Dvl TKO) (Jiang et al. 
2015) failed to activate Wnt signaling (Figure 4.4C). As control, inhibiting Fz and Dvl 
function did not inhibit Wnt signaling induced by lithium treatment (Figure 4.4D). 
These findings suggested that multiple signalosome components mediated the 
aberrant signaling resulting from APC loss. We therefore tested whether loss of APC 
induced signalosome formation. The receptor aggregates or signalosomes that form 
upon Wnt ligand activation are detectable as multi-protein complexes in sucrose density 
gradients (Bilić et al., 2007). As expected, we observed a shift in the migration of LRP6 
into the denser fractions of lysates from RKO cells treated with Wnt3a compared to 
untreated cells (Figure 4.4E). However, LRP6 was also detected in the denser fractions 
of lysates from RKO APCKO cells even in the absence of Wnt3a, suggesting aggregate 
formation (Figure 4.4E). Based on these findings, we conclude that APC loss induces 
signalosome assembly. 
We next tested if Wnt ligands were necessary for the aberrant activation of 
signaling in APC mutant cells. A chimeric protein encoding the immunoglobulin Fc 
domain fused to the cysteine-rich region of Fz8 (Fz8-Fc) sequesters Wnt ligands and 
thereby blocks Wnt pathway activation (DeAlmeida et al. 2007). Fz8-Fc inhibited Wnt 
reporter activity and -catenin accumulation in Wnt3a-treated cells (Figure 4.5A). Fz8-
Fc, however, had no effect on Wnt reporter activity in APC-deficient cells (Figures 4.5B-
D). Interestingly, APC-deficient cells were still responsive to exogenous Wnt3a 
activation, as indicated by the increase of phospho-LRP6, which was inhibited by Fz8- 
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Figure 4.5. Wnt receptor activation in APC-deficient cells is Wnt ligand 
independent.  
(A-D) Fz8-Fc blocks Wnt ligand-mediated signaling but not signaling in APC-deficient 
cells. (A) RKO STF cells were incubated with Wnt3a and Fz8-Fc at the indicated 
concentrations. (B) HEK293 STF cells transfected with APC siRNA and (C) RKO APCKO 
cells were incubated with Fz8-Fc. (D) Wnt activation in CRC cells is not dependent on 
Wnt ligand. CRC cells were incubated with Fz8-Fc at the indicated concentrations for 
48h.  
(E) APC-depleted cells are still responsive to Wnt ligand. RKO APCKO cells were pre-
incubated for 30 min with Fz8-Fc followed by incubation with Wnt3a.  
Graphs show mean ± s.e.m., n.s. non-significant, *p<0.05, **p<0.01.  
A B C 
D E 
87 
 
Fc (Figure 4.5E). We conclude that Wnt ligands are dispensable for pathway activation 
resulting from APC loss. 
To test the possible requirement for Wnt ligands using an independent approach, 
we inhibited their secretion. Palmitoylation of Wnt ligands by the O-acyltransferase 
Porcupine (PORCN), is required for their secretion and receptor binding (Gao and 
Hannoush, 2014; Janda et al., 2012). As expected, two PORCN inhibitors, Wnt-C59 
(IC50=0.1nM) and IWP-2 (IC50=27nM) (Chen et al. 2009; Proffitt et al. 2013), inhibited 
Wnt signaling in cells transfected with Wnt3a (Figure 4.6A and B) but not when Wnt3a 
was added exogenously (Figure 4.6C and D). Wnt-C59 and IWP-2 also had no 
observable effect on Wnt signaling in APC-deficient cells (Figure 4.6E-H). In contrast to 
APC mutant CRC cells, we observed a reduction in phospho-LRP6 in HCT116 cells 
upon Fz8-Fc, Wnt-C59, and IWP-2 treatment, suggesting that an autocrine feedback 
circuit occurs in HCT116 cells; reporter activity, however, was not noticeably impaired 
(Figure 4.6I and J).  
To rule out any residual PORCN activity, we knocked down APC in PORCN null 
cells, which are non-responsive to transfected Wnt3a (Barrott et al. 2011) (Figure 4.7A). 
In contrast to Dvl TKO cells, knocking down APC in PORCN null cells activated Wnt 
signaling, which was inhibited by LRP6 knockdown (Figure 4.7B). These results are 
consistent with a model in which loss of APC leads to ligand-independent activation of 
the Wnt receptors and downstream signaling.  
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Figure 4.6. PORCN is not required for Wnt activation in the absence of APC. 
(A and B) Inhibition of secreted Wnt3a by the PORCN inhibitors Wnt-C59 and IWP-2. 
HEK293 STF were transfected with Wnt3a and treated with (A) Wnt-C59 (0.3 nM)  or 
(B) IWP-2 (30 nM).  
(C and D) Wnt pathway activation by exogenously added Wnt3a is not blocked by 
PORCN inhibitors. HEK293 STF cells were pre-incubated with (C) Wnt-C59 or (D) IWP-
2 for 30 minutes followed by incubation with Wnt3a.  
(E-H) PORCN inhibition does not block Wnt activation upon loss of APC. (E and F) 
HEK293 STF cells transfected with APC siRNA and (G and H) RKO APCKO cells were 
incubated with (E and G) Wnt-C59 or (F and H) IWP-2.  
(H and I) PORCN inhibition does not block Wnt activation in CRC cells. CRC cells were 
incubated with (H) Wnt-C59 or (I) IWP-2 for 48h. 
Graphs show mean ± s.e.m., n.s. non-significant, *p<0.05. 
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Figure 4.7. LRP6 is required for Wnt activation upon loss of APC in PORCN null 
cells 
(A) PORCNKO cells are responsive to exogenous Wnt3a but not transfected Wnt3a. 
PORCNKO MEF and wild-type MEF were transfected with Wnt3a or incubated with 
exogenous Wnt3a.  
(B) LRP6 is required for Wnt activation upon loss of APC in the absence of PORCN. 
PORCNKO MEF and wild-type MEF were transfected with APC and LRP6 siRNA. 
Graphs show mean ± s.e.m., n.s. non-significant, *p<0.05, **p<0.01, ***p<0.001. 
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LRP6 and Dishevelled are required for the aberrantly increased proliferation of 
Apc1 mutant adult intestinal stem cells in Drosophila 
Similar to the consequences of APC loss in the mammalian intestine (Kinzler and 
Vogelstein 1996; Korinek et al. 1997; Sansom et al. 2004), inactivation of Drosophila 
Apc1 in adult intestinal stem cells (ISCs) results in their aberrantly increased 
proliferation (Cordero et al. 2009; Lee et al. 2009). We tested whether the ISC 
overproliferation and epithelial cell polarity defects resulting from Apc1 inactivation is 
dependent on the Drosophila homolog of LRP6 (Arrow; Arr) (Wehrli et al., 2000). By 
comparison with controls (Figure 4.8A, B, and M), a significantly increased number of 
progenitor cells (ISCs and enteroblasts), marked by their expression of esg>GFP (esg-
gal4,UAS-GFP) (Micchelli and Perrimon 2006), was observed in the posterior midgut of 
1- to 2-day-old Apc1 null mutant adults (Figure 4.8E, F, and M). In contrast, RNAi-
mediated Arrow knockdown in Apc1 null mutant intestinal progenitor cells during 
development of the adult midgut resulted in a significant reduction in progenitor cell 
number (Figure 4.8I, J, and M). Furthermore, the disrupted epithelial cell polarity in 
Apc1 null mutants, as revealed by the aberrant subcellular localization of adherens 
junction marker Armadillo (Arm) (compare Figures 4.8C and 4.8D with Figures 4.8G and 
4.8H) was also rescued by Arrow depletion (Figures 4.8K and 4.8L). To rule out off-
target effects resulting from expression of the RNAi constructs, we tested two 
independently-derived Arrow knockdown lines and obtained similar results (Figure 
4.8M). 
To further test these findings, we examined the effects RNAi-mediated 
knockdown of Apc1 either singly or with concomitant knockdown of Arrow or Dvl  
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Figure 4.8. Both ISC overproliferation and epithelial cell polarity defects in 
Drosophila Apc1 null mutant midguts are rescued by Arrow depletion. 
(A-H, and M) By comparison to controls (A-D, and M), loss of Apc1 leads to increased 
progenitor cell number (E, F, H, and M) and deregulated epithelial cell polarity in the 
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adult posterior midgut (G, H). Intestinal progenitor cells are marked with esg>GFP 
(green). Adherens junctions are marked with Arm (magenta) and nuclei with DAPI 
(blue). Enteroendocrine cells are marked with Prospero (Pros, magenta). 
(I-L, and M) Expression of Arrow RNAi constructs in Apc1 mutants leads to a significant 
reduction in progenitor cell numbers (I, J, L, and M) and rescues defects in cell polarity 
(K and L).  
(A, E, and I) Lower magnification view (scale bars: 50 m) (B-D, F-H, and J-L) higher 
magnification view (scale bar: 10 m). 
Graphs show mean ± s.e.m., ****p<0.0001, ***p<0.001. 
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Figure 4.9. Arrow and Dishevelled are required for overproliferation of midgut 
stem cells resulting from depletion of Apc1 in Drosophila.  
(A-D, and G) By comparison to controls (A, B and G), RNAi-mediated knockdown of 
Apc1 during pupation in ISCs using esgts (temperature sensitive driver) leads to an 
increase in adult midgut progenitor cell number (C, D, and G). Progenitor cells are 
marked with esg>GFP (green), and nuclei are marked with DAPI (magenta). (E-G) 
Concomitant expression of the Apc1 RNAi construct with any one of three different arr 
RNAi constructs leads to a significant reduction in progenitor cell numbers (E-G). Scale 
bar: 30 μm 
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(H-K, and N) By comparison to controls (H, I, and N), RNAi-mediated knockdown of 
Apc1 in ISCs results in an increase in progenitor cell number (J, K, and N). Apc1 
knockdown in progenitor cells during pupation was achieved by the temperature-
sensitive ISC driver, esgts. Intestinal progenitor cells are marked with esg>GFP (green). 
Nuclei are marked with DAPI (magenta). (L-N) Concomitant expression of the Apc1 
RNAi construct with either of two different dsh RNAi constructs results in a significant 
reduction in progenitor cell numbers. Scale bar: 30 μm., 
Graphs show mean ± s.e.m., *** p<0.001, **** p<0.0001.  
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(Dishevelled; dsh) (Klingensmith et al. 1994; Noordermeer et al. 1994; Siegfried et 
al.1994). Apc1, Arrow, or dsh were knocked down in ISCs during formation of the adult 
midgut using the temperature-sensitive progenitor cell driver esgts. Consistent with the 
Apc1 null mutant phenotype, knockdown of Apc1 resulted in an increase in progenitor 
cell number in the posterior midgut of 1- to 2-day-old adults (compare Figure 4.9A, B, 
and G with Figure 4.9C, D, and G). In contrast, concomitant RNAi-mediated knockdown 
of Apc1 and Arrow resulted in a significant reduction in this number (Figure 4.9E, F, and 
G). Similarly, concomitant knockdown of dsh and Apc1 also resulted in a significant 
reduction of ISC number as compared to knockdown of Apc1 alone (Figure 4.9H-N). To 
rule out RNAi off-target effects, we tested multiple independently-derived arrow and dsh 
knockdown lines and obtained similar results (Figure 4.9G and Figure 4.9N). These 
findings provide in vivo evidence that the requirement for plasma membrane 
components of the Wnt pathway for the aberrantly increased signaling in APC-deficient 
cells is evolutionarily conserved. 
 
Rapid accumulation of phospho-LRP6 and -catenin stabilization occur upon 
immediate loss of APC 
 We asked if receptor activation following APC loss was a secondary 
consequence of a simple positive feedback mechanism resulting from the regulation of 
Wnt target genes. We found that lithium treatment stabilized -catenin and promoted 
Wnt reporter activity, but, in contrast to loss of APC, did not promote phospho-LRP6 
accumulation (Figure 4.10A). We also tested the effects of a dominant-negative form of  
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Figure 4.10. LRP6 activation and -catenin accumulation occur rapidly upon loss 
of APC function. 
(A) Schematics of APC structure and truncations tested.  
(B-D) -catenin and Axin binding domains of APC are sufficient to rescue loss-of-APC 
phenotype. (E) HEK293 STF treated with APC siRNA, (F) RKO APCKO, and (G) CRC 
cells were transfected with Myc-APCT followed by TOPflash analysis and 
immunoblotting.  
(E) Loss of APC correlates with -catenin and phospho-LRP6 accumulation. RKO 
APCKO TIR1 cells were transfected with Myc-APCT or AID-Myc-mCherry-APCT 
followed by incubation with auxin. AID, auxin-inducible degron; mCh, mCherry; Aux, 
auxin.  
Graphs show mean ± s.e.m., n.s. non-significant, *p<0.05, **p<0.01, ***p<0.001. 
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TCF4 (dnTCF4) (van de Wetering et al. 2002) that prevents TCF-mediated expression 
of Wnt target genes. We found that dnTCF4 inhibited reporter activation, but not 
accumulation of either -catenin or phospho-LRP6, upon APC knockdown (Figure 
4.10B and C). Thus, stabilization of -catenin and activation of Wnt target genes are not 
sufficient to activate Wnt receptors upon APC loss. 
 APC exhibits multiple activities in addition to its role in Wnt signaling (Saito-Diaz 
et al., 2012). The aberrant activation of Wnt signaling in APC mutant cells is rescued by 
an APC fragment (APCT) containing its -catenin and Axin binding domains (Li et al. 
2012) (Figure 4.10A). We found that APCT suppresses LRP6 phosphorylation in APC-
deficient cells (Figure 4.10B-D), suggesting that LRP6 activation in APC mutant cells is 
due to loss of the region of APC associated with its Wnt pathway function. If formation 
of an active Wnt receptor complex is not due to a transcriptional/translational feedback 
mechanism in APC-deficient cells, LRP6 phosphorylation and -catenin stabilization 
upon APC loss should be temporally correlated. To test this hypothesis, we investigated 
the timing of LRP6 phosphorylation and -catenin accumulation following APC loss. We 
fused the APCT fragment to an auxin-inducible degron (AID) that allows for auxin-
induced turnover (Holland et al. 2012) by the plant E3 TIR1 protein (Figure 4.10A). 
Transfection of AID-Myc-mCherry-APCT into RKO APCKO cells stably expressing E3 
TIR1 suppresses Wnt signaling to a similar extent as the APCT fragment (Figure 4.10E, 
compare left and right panels). The addition of auxin resulted in a rapid loss of AID-Myc-
mCherry-APCT (within 30 minutes) that paralleled the stabilization of -catenin. 
Significantly, the accumulation of -catenin levels paralleled the appearance of 
phospho-LRP6 (Figure 4.10E, right panel).  
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Endocytosis is required for Wnt signaling upon loss of APC 
 Endocytosis is required for receptor-mediated activation of the Wnt pathway 
(Blitzer and Nusse 2006; Yamamoto et al. 2006; Gagliardi et al. 2014). As expected, we 
found that blocking endocytosis by shifting Wnt3a-treated RKO or RKO APCKO cells to 
4˚C decreased cytoplasmic -catenin and phospho-LRP6 levels; this effect was 
reversed by shifting cells back to 37˚C. In contrast, activating RKO cells with lithium had 
no effect on cytoplasmic -catenin levels when incubated at 4˚C (Figure 4.11A-D). 
Similarly, we found that shifting SW480 (APC mutant), but not HC116 (-catenin 
mutant) cells, to 4°C decreased cytoplasmic -catenin levels (Figure 4.12). To test the 
requirement for endocytosis further, we used a dominant-negative Dynamin 
(DynaminK44A), which inhibits both clathrin and caveolin-mediated endocytosis and has 
been shown to inhibit Wnt signaling (Blitzer and Nusse 2006; Yamamoto et al. 2008; 
Dutta and Donaldson 2012). DynaminK44A decreased -catenin levels in all APC-
deficient cell lines tested (Figure 4.13A-D). 
Given that we found that Dynamin is required for Wnt pathway activation in APC-
deficient cells, we asked whether LRP6 is internalized upon loss of APC. Consistent 
with previous reports (Yamamoto et al., 2006), we found that LRP6 was internalized 
within two hours after addition of Wnt3a and could be blocked with mAb7E5 (Figure 
4.14A). As expected, lithium had no effect on LRP6 internalization. Internalization of 
LRP6 induced by APC knockdown was blocked with mAb7E5 but not with PORCN 
inhibitors (Figure 4.14B and C). In RPE cells, fluorescence intensity profiles from an 
axial scan showed two distinct peaks of LRP6-eYFP signal cells that corresponded to  
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Figure 4.11. Endocytosis inhibition induced by temperature shift prevents -
catenin accumulation and LRP6 phosphorylation. 
(A-D) RKO cells (treated with Wnt3a or 30 mM LiCl), and RKO APCKO cells were 
incubated at 4°C (A and B) and shifted back to 37°C (C and D). The average of three 
independent replicates were plotted. 
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Figure 4.12. Endocytosis inhibition induced by temperature shift prevents -
catenin accumulation in APC-mutant CRC cells. 
CRC cells were incubated at 4°C. Lysates were obtained at specified times and analyzed 
by immunoblotting. The average of three independent replicates were plotted. Blot are 
representative experiments. 
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Figure 4.13. Dynamin is required for Wnt signaling in the absence of functional 
APC. 
(A) Schematics of Dynamin function in endocytosis. 
(B) Dynamins is required for Wnt activation. HEK293 STF cells incubated with Wnt3a or 
APC siRNA and transfected with HA-DynaminK44A  
(C and D) Dynamin is required for Wnt signaling upon loss of APC function. (C) RKO 
APCKO cells and (D) CRC cells were transfected with HA-DynaminK44A.  
Graphs show mean ± s.e.m., n.s. non-significant, *p<0.05, **p<0.01, ***p<0.001. 
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Figure 4.14. LRP6 is internalized in APC-deficient cells. 
(A and B) LRP6 is internalized in Wnt3a treated and APC deficient cells. RPE cells were 
transfected with LRP6-eYFP and incubated with Wnt3a or 30mM LiCl or (B) APC siRNA 
and mAb7E5. Cells (>100/condition) demonstrating membrane or internalized LRP6 
were quantified.  
(C) PORCN inhibition does not block LRP6 internalization upon loss of APC. RPE 
shAPC cells were transfected with LRP6-eYFP and incubated with Wnt-C59 or IWP-2.  
(D) Loss of APC promotes LRP6 internalization. RPE cells were transfected with LRP6-
eYFP and APC siRNA in the absence or presence of mAb7E5. Line scans were 
performed to quantify changes in LRP6 intensity across cells.  
Scale bars: 20 m. 
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high concentrations of LRP6 at the plasma membrane. In contrast, APC-depleted cells, 
we observed multiple peaks corresponding to previously reported large, punctate, 
LRP6-containing structures postulated to represent intracellular vesicles (Bilić et al., 
2007). Treatment of APC-depleted cells with mAb7E5 re-established the formation of 
two predominant peaks of fluorescence signal (Figure 4.14D). These studies provide 
further evidence that the endocytic pathway is required to activate the Wnt pathway in 
APC-deficient cells. 
 
Wnt receptor activation in APC-deficient cells occurs via a clathrin-dependent 
mechanism. 
 Clathrin- and caveolin-mediated endocytosis have both been implicated in Wnt 
signaling (Blitzer and Nusse 2006; Yamamoto et al. 2006; Bilić et al. 2007; Hanson et 
al. 2013). Chloroquine and nystatin are small molecule inhibitors of clathrin- and 
caveolin-mediated endocytosis, respectively (Yamamoto et al. 2006; Chen et al. 2009; 
Dutta and Donaldson 2012). Consistent with a previous study (Yamamoto et al., 2006), 
nystatin, but not chloroquine, inhibited Wnt3a-mediated accumulation of -catenin in 
RKO cells (Figure 4.15A and B). In RKO APCKO cells, however, chloroquine and pitstop-
2 (another inhibitor of clathrin-mediated endocytosis) (Dutta et al. 2012) decreased -
catenin, whereas nystatin had no observable effect (Figure 4.15C-F). To confirm these 
results, we knocked down clathrin and caveolin (Figure 4.16A and B). Knocking down 
caveolin, but not clathrin, inhibited Wnt3a signaling in RKO cells (Figure 4.16C). In 
contrast, knocking down clathrin, but not caveolin, inhibited Wnt signaling in RKO  
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Figure 4.15. Ligand-dependent and -independent Wnt activation requires distinct 
endocytic pathways. 
(A-C) RKO cells incubated with Wnt3a were treated with indicated concentrations of 
nystatin, chloroquine, or Pitstop-2. Followed by immunoblotting. 
A B 
C 
D E 
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(D-F) RKO APCKO cells were treated with indicated concentrations of nystatin, 
chloroquine, or Pitstop-2. Followed by immunoblotting. 
The average of three independent replicates were plotted. Blot are representative 
experiments. 
Graphs show mean ± s.e.m., n.s. non-significant, *p<0.05, **p<0.01, ***p<0.001. 
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Figure 4.16. Clathrin-mediated endocytosis is required for Wnt activation upon 
loss of APC. 
(A) Downregulation of clathrin by siRNAs. RKO cells were incubated with two different 
siRNAs.  
(B) Two distinct siRNAs decrease caveolin levels. RKO cells were incubated with two 
siRNAs. 
(C) RKO cells incubated with Wnt3a were transfected with caveolin-1 or clathrin siRNA.  
(D) RKO APCKO cells were transfected with clathrin or caveolin-1 siRNA. 
(E) Inhibition of clathrin-mediated endocytosis blocks LRP6 endocytosis in APC-
depleted cells. RPE and RPE shAPC were incubated with chloroquine, Pitstop-2, and 
nystatin, and live cells were imaged by confocal microscopy. 
(F) Clathrin requirement for Wnt activation upon loss of APC is conserved. L-cells were 
incubated with Wnt3a or APC siRNA and treated with chloroquine or nystatin.  
(G) Wnt activation upon loss of APC is caveolin-1-independent. Caveolin-1KO MEFs 
were incubated with Wnt3a or APC siRNA.  
Graphs show mean ± s.e.m., *p<0.05, **p<0.01, ***p<0.001. 
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Figure 4.17. APC forms a complex with clathrin.  
(A-C) APC partially colocalizes with clathrin but not caveolin-1. RPE cells were 
incubated with or without Wnt3a, fixed, and stained for APC and (A) Clathrin or (B) 
caveolin-1. Scale bar: 10m. (C) Intensity correlation analysis of APC-clathrin/caveolin-
1 signal.  
(D) APC co-immunoprecipitates with clathrin and its adaptor protein, AP2  
Graph show mean ± s.e.m., n.s. non-significant, *p<0.05, **p<0.01. 
C 
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APCKO cells (Figure 4.16D). We next assessed whether treatment with chloroquine, 
pitstop-2, or nystatin altered LRP6-eYFP accumulation at the plasma membrane, 
whereas nystatin treatment had no observable effect (Figure 4.16E). These studies 
provide further evidence that Wnt signaling in APC-depleted cells occurs via a clathrin-
mediated mechanism.  
 A previous study showed that disruption of clathrin-mediated endocytosis in 
mouse fibroblasts L-cells inhibits Wnt ligand-mediated activation (Blitzer and Nusse, 
2006). We found that Wnt3a signaling in L-cells is mediated by both clathrin and 
caveolin-pathways (Figure 4.16F). Wnt pathway activation upon APC knockdown, 
however, is a clathrin-dependent process in both L-cells (Figure 4.16F), and in a MEF 
cell line deficient for caveolin (Hanson et al., 2013) (Figure 4.16G). Thus, the 
requirement for caveolae versus clathrin for Wnt ligand activation appears to be cell-
type dependent, whereas clathrin is specifically required for constitutive Wnt pathway 
activation in APC-deficient cells regardless of cell type.  
 Finally, we tested whether endogenous APC forms a complex with endogenous 
clathrin. Immunofluorescence microscopy studies revealed significant overlap of APC 
with clathrin, but not caveolin, at the plasma membrane in RPE cells (Figure 4.17A-C). 
To further test these results using a biochemical approach, we performed co-
immunoprecipitation studies and found that endogenous APC was pulled down with 
clathrin and its adaptor protein, AP-2, but not caveolin (Figure 4.17D).  
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Discussion 
 Despite extensive investigation, the mechanistic basis for APC function in Wnt 
signaling has remained an enigma (Saito-Diaz et al., 2012). Based on our studies, we 
propose that a major role of APC is to prevent constitutive, ligand-independent, clathrin-
dependent signalosome formation and pathway activation (Figure 4.18). Our findings 
are not inconsistent with the role for APC in -catenin phosphorylation and degradation 
(Clevers and Nusse 2012). APC and APC2 are functionally redundant in some contexts 
(Ahmed et al. 2002; Daly et al. 2016). Thus, in the absence of APC, APC2 could act as 
the primary scaffold protein in the -catenin degradation complex. This could explain 
why -catenin can still be degraded in cells upon loss of APC when the Wnt receptor 
complex is disrupted; APC2 is able to associate with the degradation complex to 
promote -catenin turnover 
 Previous studies provide evidence for both caveolin and clathrin-based 
mechanisms in the activation of the Wnt pathway (Bilić et al., 2007; Blitzer and Nusse, 
2006; Hanson et al., 2013; Yamamoto et al., 2006). Consistent with this possibility, we 
observed that epithelial cells (e.g., HEK293, RKO and RPE cells) mediate Wnt signaling 
via the caveolin pathway, whereas fibroblasts (e.g., L-cells and MEFs) mediate Wnt 
signaling via the clathrin pathway. Because caveolin- and clathrin-dependent 
endocytotic pathways differ in their dynamic association with the plasma membrane, 
Wnt signaling could potentially be qualitatively different depending on the particular 
pathway utilized. In addition, clathrin-dependent endocytosis has been linked to an early 
response to stimuli, whereas caveolae play a later role in maintaining responses (Zhang 
et al. 2014). The clathrin-mediated pathway can be promiscuous: a well-known example  
115 
 
 
 
 
Figure 4.18. Proposed model for APC functioning as a negative regulator of 
clathrin-mediated endocytosis of Wnt pathway membrane components.  
(A) In the absence of a Wnt ligand, LRP6 localizes in nascent Clathrin-coated pits. APC 
forms a complex with clathrin to block spontaneous Wnt receptor aggregation and 
activation.  
(B) Wnt binds to its co-receptors, Fz and LRP6, to promote signalosome formation. The 
Wnt signalosome is internalized via the caveolae or clathrin pathways.  
A 
B 
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(C) Loss of APC results in ligand-independent LRP6 oligomerization, Wnt signalosome 
formation, and pathway activation via the clathrin endocytic pathway. This event drives 
constitutive activation of the Wnt pathway.  
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is the constitutive internalization of the transferrin receptor. Thus, it is possible that APC 
acts as a “brake” on receptor activation via the clathrin endocytic pathway in the 
absence of Wnt ligand. Future studies will focus on the detailed mechanism by which 
APC regulates this process. 
 
 
  
118 
 
CHAPTER V 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
Since the discovery of the Wnt signaling pathway, much of the work has focused 
on understanding the regulatory steps in the pathway as well as identifying targets for 
developing therapeutics against Wnt-driven diseases. The work presented herein 
provides insight into both areas of investigation. In this Chapter, I will briefly summarize 
my findings and describe important questions that arose from my work. 
 
Biochemical characterization of mAb7E5 
We identified the monoclonal antibody mAb7E5 that targets the extracellular 
domain of LRP6. Using biochemical analysis, we identified that mAb7E5 inhibits ligand- 
dependent and independent Wnt activation. We found that mAb7E5 binds to the LRP6-
2 and LRP6-3 fragments of human LRP6. Our working hypothesis is that mAb7E5 
blocks the LRP6 conformational change required to effectively transduce the Wnt signal 
from the plasma membrane to downstream, cytoplasmic effectors. Further studies are 
needed to more accurately identify the region(s) where mAb7E5 binds to LRP6. This 
may be readily accomplished by performing binding assays with a series of LRP6 
truncations and point mutations to further narrow the mAb7E5 binding domain on LRP6. 
Ideally, these results will ultimately be confirmed by analyzing the X-ray crystal structure 
of mAb7E5 bound to LRP6. Such a structure may provide important insight into the 
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mechanism by which Wnt ligand can induces the conformation of LRP6 to promote its 
activation.  
Regulation of endocytosis by APC 
Loss of APC results in constitutive activation of the Wnt pathway. This was 
thought to occur primarily by disrupting the assembly of the -catenin degradation 
complex, thereby bypassing the need for activation of membrane receptors 
components. Based on my studies, a new role for APC function in the Wnt pathway is 
revealed that does not involve its role in the degradation complex.  My studies indicate 
that APC prevents inappropriate activation of the membrane components of the Wnt 
pathway via the clathrin endocytic pathway. To my knowledge, this is the first time such 
a phenomenon has been demonstrated to occur in the Wnt pathway. Significantly, loss 
of APC resulting in Wnt pathway activation via the clathrin endocytic pathway is ligand-
independent and is, thus, cell autonomous. Although p53 and Ras mutant cancer cells 
have been shown to exhibit high rates of receptor endocytosis (Mellman and Yarden 
2013), the process that links the endocytic pathway and cell signaling remains poorly 
understood.  
Signaling pathways rely on exquisite mechanisms to effectively transduce 
external cues to downstream effectors. Consistent with this, a growing body of evidence 
links endocytosis to activation of the Wnt pathway however the mechanism is not clear. 
Both clathrin and caveolin have been reported to be required for LRP6 endocytosis and 
Wnt pathway activation (Blitzer and Nusse 2006; Yamamoto et al. 2006). I found that 
whether the clathrin or the caveolin endocytic machinery is required for Wnt ligand-
mediated signaling is highly dependent on the particular cell type tested. I found, 
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however, that activation of the Wnt pathway upon APC loss is clathrin-mediated and is 
independent of cell type. Why would a cell require two different endocytic pathways to 
regulate Wnt signaling? It is possible that Wnt activation mediated by clathrin and 
caveolin-dependent endocytosis is qualitatively different and may be required in 
different biological contexts (e.g. during development). Future studies should focus on 
understanding whether there are qualitative differences in Wnt signaling that occur via 
the clathrin versus the caveolin pathway. 
The evolutionary conservation between Drosophila and vertebrate in the 
regulation of Wnt signaling by APC suggests that this mechanism may play a critical 
role in early animal development. Interestingly, Drosophila do not express caveolin 
suggesting that caveolin-mediated Wnt activation may be a more evolutionarily recent 
development in vertebrates (Fischer et al. 2006). Although the Wnt pathway is highly 
conserved, some differences in how Wnt signaling is regulated between Drosophila and 
vertebrates are not unexpected, particularly when it involves regulation of Wnt receptor 
activity. For example, secreted Wnt inhibitors (e.g. Dkk1 and Sfrp-1) and the Wnt 
agonist, R-Spondin, are present in vertebrates but not in Drosophila. Wnt signaling has 
been proposed to be critical for the evolution of epithelial morphogenesis (Lapébie et al. 
2009). Interestingly, Wnt signaling via the caveolin pathway occur primarily in 
mesodermal cells and may reflect an evolutionary requirement in vertebrate for Wnt 
signaling in patterning mesenchymal tissues. 
We found that APC associates with clathrin by coimmunoprecipitation. One 
possible model is that LRP6 is present in nascent clathrin coated pits, and APC acts as 
a brake to block the activity of the LRP6-bound clathrin. Upon Wnt stimulation, LRP6 
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subsequently translocates to mature clathrin vesicles where it is ultimately activated 
upon internalization of the clathrin vesicles. Careful colocalization studies of APC, 
clathrin, and LRP6 by electron microscopy may provide a better (high resolution) 
understanding of their spatial and temporal regulation upon Wnt ligand activation. 
My findings demonstrate that inhibiting the activities of LRP6, Fz, or Dvl result in 
-catenin downregulation (and inhibition of Wnt signaling) in APC-deficient cells. These 
studies suggest that the -catenin destruction complex remains fully functional upon 
loss of APC. APC and APC2 have been proposed to exhibit redundant functions 
(Ahmed et al. 2002; Daly et al. 2016). In Drosophila, overactivation of Wg signaling due 
to inactivation of one of the APC proteins can be inhibited by overexpression of the 
other Apc (Ahmed et al. 2002). Loss of both APC and APC2 disrupts mammary tissue 
homeostasis and promotes mammary tumor formation in mice (Daly et al. 2016). This 
study suggests that APC and APC2 may act in a redundant fashion to promote 
tumorigenesis in certain tissues. 
Despite their functional redundancy in human cells, APC2 shows lower affinity to 
-catenin and is less efficient promoting its turnover compared to APC (Schneikert et al. 
2013). Thus, I hypothesize that in the absence of APC, APC2 functions as the 
predominant scaffold (along with Axin) in the -catenin degradation complex. One would 
predict that inhibiting the function of LRP6, Fz, or Dvl would no longer be able to 
promote -catenin downregulation in APC-APC2 double knockdowns. The vast majority 
of human cancers occur due to disruption of APC (not APC2) function. Also, APC 
mutant CRC cells express APC2. One possibility is that only APC can block Wnt-ligand 
independent activation of the Wnt signaling by the clathrin-endocytic pathway. Thus, 
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loss of APC cannot be fully compensated by APC2. Further experiments should be 
performed to test this possibility.  
My work supports a role for APC regulating the function of the -catenin 
destruction complex and the activation of plasma membrane components. It is unclear 
which of these two activities represent the “the main function” of APC in the Wnt 
pathway. I have shown that a fragment of APC encoding the -catenin and Axin-binding 
domains (APCT) is sufficient to prevent LRP6 phosphorylation and -catenin turnover in 
APC-depleted cells, suggesting that both events are dependent on APC function. One 
possible explanation is that independent pools of APC regulate each event. However, if 
this were true, APCT degradation would only affect -catenin degradation and not LRP6 
activation because it only binds to Axin and -catenin. Another explanation is that both 
functions are not mutually exclusive and APC regulates both the -catenin destruction 
complex function and LRP6 activation. The multiple roles of APC in the Wnt pathway is 
reminiscent of the role of GSK3 in the destruction complex and receptor activation. 
Further experiments, are necessary to understand the precise mechanism of APC 
action, particularly at the membrane. 
Tight regulation of Wnt signal transduction is necessary for proper development 
of all metazoans. In adults, APC inhibition is involved in early development of colorectal 
adenocarcinomas. Because homozygous deletion of APC is embryonic lethal (Dow et 
al. 2015), the effects caused by APC loss are typically studied in the context of disease 
in fully developed organisms in which conditional knockouts can be performed. Indeed, 
loss of APC function in adult mice deregulates the Wnt pathway and recapitulates the 
molecular features of CRC. Furthermore, experimental APC restoration reestablishes 
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intestinal crypt homeostasis in APC-deficient mice (Chartier et al. 2016). Given the 
seemingly elaborate mechanism by which APC regulates Wnt receptor activation, one 
could hypothesize that regulating APC levels may represent another way by which the 
pathway can be activated in a cell autonomous fashion (independent of Wnt ligands) 
during certain normal developmental processes. This is not without precedence. Albeit, 
via a distinct mechanism, Notch signaling can also occur via a ligand-independent 
manner involving endocytosis of the Notch receptor (Palmer and Deng 2015). In 
Drosophila, the hematopoietic crystal cells exhibit ligand-independent Notch pathway 
activation at the endosome that promotes their survival during development (Mukherjee 
et al. 2011). Thus, ligand-independent activation during development might be 
advantageous in a context where there is no guaranteed ligand source. Further 
experiments will be required to test our hypothesis that downregulating APC levels 
represents a normal developmental mechanism to activate the Wnt pathway in a cell 
autonomous manner. 
 
Targeting LRP6 in TNBC and CRC 
We found that mAb7E5 inhibits the Wnt pathway in triple negative breast cancer 
(TNBC) and colorectal cancer (CRC) cells, suggesting that mAb7E5 could be developed 
further as a therapeutic agent to treat Wnt-driven tumors. Our preliminary study 
indicated that mAb7E5 inhibit Wnt signaling in the TNBC cell line, MDA-MB-231. 
Previous reports have shown that LRP6 expression is upregulated in TNBC, and RNAi 
knockdown of LRP6 results in inhibition of the Wnt pathway and decreased cellular 
growth/proliferation (Liu et al. 2010).   
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Receptor activation in APC-mutant colorectal cancer cells has not been 
previously studied in detail.  Past studies suggested that constitutive activation of the 
Wnt pathway in CRC may occur via an autocrine signal loop (Voloshanenko et al. 
2013). In the current study, I found that inhibition of Porcupine (PORCN), the protein 
required for Wnt secretion and function, was not sufficient to inhibit -catenin 
accumulation and loss of APC in PORCN null cells did not inhibit transcriptional 
activation of a Wnt reporter. These results suggest that an autocrine Wnt signal is 
unlikely to play a major role in Wnt pathway activation upon loss of APC.  Thus, future 
therapeutic approaches to target APC mutant tumors should focus on disrupting the 
receptors and other Wnt signaling components necessary for formation of active 
receptor complexes (e.g., signalosomes) other than Wnt ligands. Our own studies with 
mAb7E5 suggest that it may represent an attractive candidate to target CRC.   
If the utility of mAb7E for treating TNBC and APC mutant CRC is to be fully 
realized, further studies are required to test whether mAb7E5 is effective in in vivo 
tumor models (either cancer cell line xenografts or patient derived xenografts). Other 
tasks that will be required for its development as a therapeutic agent include the 
development and testing of a humanized version of the antibody (mAb7E5 is a mouse 
monoclonal) as well as assessing its bioavailability, in vivo half-life, and 
pharmacodynamics/pharmacokinetics.  
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Concluding remarks 
The work presented herein combines multiple approaches to understand the 
mechanism of Wnt signaling transduction. We identified a new function of the tumor 
suppressor, APC, that provides a link between a basic cell biological process 
(endocytosis) with the Wnt signaling pathway. The current work highlights the 
importance of studying signaling pathways as part of a complex system that is regulated 
in a temporal and spatial fashion and not simply as an isolated biochemical cascade of 
events. It is likely that every signaling pathway is ultimately interconnected to form 
complex signaling networks that are tightly regulated by the cell in a similar manner. 
Thus, to understand how cells respond to their environment, we must take into account 
this level of complexity, which represents an exciting challenge for scientists studying 
how diverse chemically encoded information is organized to regulate behavior at the 
cellular and organismal level. 
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